{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyP5US5ELRHHHLUAUYGACd5r",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/Ananyaa-Perumalsamy/Ananyaa-Perumalsamy/blob/main/PS_1_docu3C.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PBHmX0V516-G",
        "outputId": "f9fa3922-8dd5-4ef4-d887-70a40b89ee56"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: scikit-learn in /usr/local/lib/python3.11/dist-packages (1.6.1)\n",
            "Requirement already satisfied: numpy>=1.19.5 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (1.26.4)\n",
            "Requirement already satisfied: scipy>=1.6.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (1.13.1)\n",
            "Requirement already satisfied: joblib>=1.2.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (1.4.2)\n",
            "Requirement already satisfied: threadpoolctl>=3.1.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (3.5.0)\n",
            "Collecting pdfplumber\n",
            "  Using cached pdfplumber-0.11.5-py3-none-any.whl.metadata (42 kB)\n",
            "Collecting pdfminer.six==20231228 (from pdfplumber)\n",
            "  Downloading pdfminer.six-20231228-py3-none-any.whl.metadata (4.2 kB)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (11.1.0)\n",
            "Collecting pypdfium2>=4.18.0 (from pdfplumber)\n",
            "  Downloading pypdfium2-4.30.1-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (48 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m48.2/48.2 kB\u001b[0m \u001b[31m2.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (3.4.1)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.11/dist-packages (from cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (1.17.1)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.11/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (2.22)\n",
            "Downloading pdfplumber-0.11.5-py3-none-any.whl (59 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m59.5/59.5 kB\u001b[0m \u001b[31m2.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer.six-20231228-py3-none-any.whl (5.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.6/5.6 MB\u001b[0m \u001b[31m45.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdfium2-4.30.1-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.9 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.9/2.9 MB\u001b[0m \u001b[31m79.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pypdfium2, pdfminer.six, pdfplumber\n",
            "Successfully installed pdfminer.six-20231228 pdfplumber-0.11.5 pypdfium2-4.30.1\n",
            "Collecting PyPDF2\n",
            "  Downloading pypdf2-3.0.1-py3-none-any.whl.metadata (6.8 kB)\n",
            "Downloading pypdf2-3.0.1-py3-none-any.whl (232 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m232.6/232.6 kB\u001b[0m \u001b[31m3.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: PyPDF2\n",
            "Successfully installed PyPDF2-3.0.1\n"
          ]
        }
      ],
      "source": [
        "!pip install scikit-learn\n",
        "!pip install pdfplumber\n",
        "!pip install PyPDF2"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import files\n",
        "uploaded = files.upload()\n",
        "\n",
        "pdf_path = list(uploaded.keys())[0]\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 73
        },
        "id": "B1ICDMdO1-pa",
        "outputId": "b73ba7f1-f13e-4105-d63c-0bfd3aab77d7"
      },
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-d71b09f1-a195-48d1-96ae-ddf4a8007c83\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-d71b09f1-a195-48d1-96ae-ddf4a8007c83\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script>// Copyright 2017 Google LLC\n",
              "//\n",
              "// Licensed under the Apache License, Version 2.0 (the \"License\");\n",
              "// you may not use this file except in compliance with the License.\n",
              "// You may obtain a copy of the License at\n",
              "//\n",
              "//      http://www.apache.org/licenses/LICENSE-2.0\n",
              "//\n",
              "// Unless required by applicable law or agreed to in writing, software\n",
              "// distributed under the License is distributed on an \"AS IS\" BASIS,\n",
              "// WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n",
              "// See the License for the specific language governing permissions and\n",
              "// limitations under the License.\n",
              "\n",
              "/**\n",
              " * @fileoverview Helpers for google.colab Python module.\n",
              " */\n",
              "(function(scope) {\n",
              "function span(text, styleAttributes = {}) {\n",
              "  const element = document.createElement('span');\n",
              "  element.textContent = text;\n",
              "  for (const key of Object.keys(styleAttributes)) {\n",
              "    element.style[key] = styleAttributes[key];\n",
              "  }\n",
              "  return element;\n",
              "}\n",
              "\n",
              "// Max number of bytes which will be uploaded at a time.\n",
              "const MAX_PAYLOAD_SIZE = 100 * 1024;\n",
              "\n",
              "function _uploadFiles(inputId, outputId) {\n",
              "  const steps = uploadFilesStep(inputId, outputId);\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  // Cache steps on the outputElement to make it available for the next call\n",
              "  // to uploadFilesContinue from Python.\n",
              "  outputElement.steps = steps;\n",
              "\n",
              "  return _uploadFilesContinue(outputId);\n",
              "}\n",
              "\n",
              "// This is roughly an async generator (not supported in the browser yet),\n",
              "// where there are multiple asynchronous steps and the Python side is going\n",
              "// to poll for completion of each step.\n",
              "// This uses a Promise to block the python side on completion of each step,\n",
              "// then passes the result of the previous step as the input to the next step.\n",
              "function _uploadFilesContinue(outputId) {\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  const steps = outputElement.steps;\n",
              "\n",
              "  const next = steps.next(outputElement.lastPromiseValue);\n",
              "  return Promise.resolve(next.value.promise).then((value) => {\n",
              "    // Cache the last promise value to make it available to the next\n",
              "    // step of the generator.\n",
              "    outputElement.lastPromiseValue = value;\n",
              "    return next.value.response;\n",
              "  });\n",
              "}\n",
              "\n",
              "/**\n",
              " * Generator function which is called between each async step of the upload\n",
              " * process.\n",
              " * @param {string} inputId Element ID of the input file picker element.\n",
              " * @param {string} outputId Element ID of the output display.\n",
              " * @return {!Iterable<!Object>} Iterable of next steps.\n",
              " */\n",
              "function* uploadFilesStep(inputId, outputId) {\n",
              "  const inputElement = document.getElementById(inputId);\n",
              "  inputElement.disabled = false;\n",
              "\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  outputElement.innerHTML = '';\n",
              "\n",
              "  const pickedPromise = new Promise((resolve) => {\n",
              "    inputElement.addEventListener('change', (e) => {\n",
              "      resolve(e.target.files);\n",
              "    });\n",
              "  });\n",
              "\n",
              "  const cancel = document.createElement('button');\n",
              "  inputElement.parentElement.appendChild(cancel);\n",
              "  cancel.textContent = 'Cancel upload';\n",
              "  const cancelPromise = new Promise((resolve) => {\n",
              "    cancel.onclick = () => {\n",
              "      resolve(null);\n",
              "    };\n",
              "  });\n",
              "\n",
              "  // Wait for the user to pick the files.\n",
              "  const files = yield {\n",
              "    promise: Promise.race([pickedPromise, cancelPromise]),\n",
              "    response: {\n",
              "      action: 'starting',\n",
              "    }\n",
              "  };\n",
              "\n",
              "  cancel.remove();\n",
              "\n",
              "  // Disable the input element since further picks are not allowed.\n",
              "  inputElement.disabled = true;\n",
              "\n",
              "  if (!files) {\n",
              "    return {\n",
              "      response: {\n",
              "        action: 'complete',\n",
              "      }\n",
              "    };\n",
              "  }\n",
              "\n",
              "  for (const file of files) {\n",
              "    const li = document.createElement('li');\n",
              "    li.append(span(file.name, {fontWeight: 'bold'}));\n",
              "    li.append(span(\n",
              "        `(${file.type || 'n/a'}) - ${file.size} bytes, ` +\n",
              "        `last modified: ${\n",
              "            file.lastModifiedDate ? file.lastModifiedDate.toLocaleDateString() :\n",
              "                                    'n/a'} - `));\n",
              "    const percent = span('0% done');\n",
              "    li.appendChild(percent);\n",
              "\n",
              "    outputElement.appendChild(li);\n",
              "\n",
              "    const fileDataPromise = new Promise((resolve) => {\n",
              "      const reader = new FileReader();\n",
              "      reader.onload = (e) => {\n",
              "        resolve(e.target.result);\n",
              "      };\n",
              "      reader.readAsArrayBuffer(file);\n",
              "    });\n",
              "    // Wait for the data to be ready.\n",
              "    let fileData = yield {\n",
              "      promise: fileDataPromise,\n",
              "      response: {\n",
              "        action: 'continue',\n",
              "      }\n",
              "    };\n",
              "\n",
              "    // Use a chunked sending to avoid message size limits. See b/62115660.\n",
              "    let position = 0;\n",
              "    do {\n",
              "      const length = Math.min(fileData.byteLength - position, MAX_PAYLOAD_SIZE);\n",
              "      const chunk = new Uint8Array(fileData, position, length);\n",
              "      position += length;\n",
              "\n",
              "      const base64 = btoa(String.fromCharCode.apply(null, chunk));\n",
              "      yield {\n",
              "        response: {\n",
              "          action: 'append',\n",
              "          file: file.name,\n",
              "          data: base64,\n",
              "        },\n",
              "      };\n",
              "\n",
              "      let percentDone = fileData.byteLength === 0 ?\n",
              "          100 :\n",
              "          Math.round((position / fileData.byteLength) * 100);\n",
              "      percent.textContent = `${percentDone}% done`;\n",
              "\n",
              "    } while (position < fileData.byteLength);\n",
              "  }\n",
              "\n",
              "  // All done.\n",
              "  yield {\n",
              "    response: {\n",
              "      action: 'complete',\n",
              "    }\n",
              "  };\n",
              "}\n",
              "\n",
              "scope.google = scope.google || {};\n",
              "scope.google.colab = scope.google.colab || {};\n",
              "scope.google.colab._files = {\n",
              "  _uploadFiles,\n",
              "  _uploadFilesContinue,\n",
              "};\n",
              "})(self);\n",
              "</script> "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Saving Amicus Brief on Behalf of Mississippi, Alabama, Alaska, Arkansas etc....pdf to Amicus Brief on Behalf of Mississippi, Alabama, Alaska, Arkansas etc....pdf\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pdfplumber\n",
        "\n",
        "def extract_text(pdf_path):\n",
        "    with pdfplumber.open(pdf_path) as pdf:\n",
        "        text = ''\n",
        "        for page in pdf.pages:\n",
        "            text += page.extract_text()\n",
        "    return text\n",
        "\n",
        "document_text = extract_text(pdf_path)\n"
      ],
      "metadata": {
        "id": "jECvkGsd2lOx"
      },
      "execution_count": 8,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import nltk\n",
        "nltk.download('stopwords')\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "axQvNcbJ3bJX",
        "outputId": "3bb6c17c-9ea6-4bc5-85d7-af915220ac7a"
      },
      "execution_count": 10,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Unzipping corpora/stopwords.zip.\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "execution_count": 10
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import spacy\n",
        "from nltk.corpus import stopwords\n",
        "import string\n",
        "\n",
        "nlp = spacy.load('en_core_web_sm')\n",
        "stop_words = set(stopwords.words('english'))\n",
        "\n",
        "def preprocess_text(text):\n",
        "    doc = nlp(text)\n",
        "    tokens = [token.lemma_ for token in doc if token.text not in stop_words and token.text not in string.punctuation]\n",
        "    return ' '.join(tokens)\n",
        "\n",
        "preprocessed_text = preprocess_text(document_text)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "L0fAwRKk3OeB",
        "outputId": "da2732b8-4cd4-4679-d363-3c2b44224893"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/util.py:1740: UserWarning: [W111] Jupyter notebook detected: if using `prefer_gpu()` or `require_gpu()`, include it in the same cell right before `spacy.load()` to ensure that the model is loaded on the correct device. More information: http://spacy.io/usage/v3#jupyter-notebook-gpu\n",
            "  warnings.warn(Warnings.W111)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from sklearn.feature_extraction.text import TfidfVectorizer\n",
        "\n",
        "vectorizer = TfidfVectorizer()\n",
        "X = vectorizer.fit_transform([preprocessed_text])\n"
      ],
      "metadata": {
        "id": "LmyUVZA43eR5"
      },
      "execution_count": 12,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install --upgrade pip\n",
        "!pip install pdfplumber transformers spacy scikit-learn datasets nltk\n",
        "!python -m spacy download en_core_web_sm"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wn2cMeVw38uK",
        "outputId": "28c1faae-ca39-47ad-82bd-9866459a3eec"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pip in /usr/local/lib/python3.11/dist-packages (24.1.2)\n",
            "Collecting pip\n",
            "  Downloading pip-25.0-py3-none-any.whl.metadata (3.7 kB)\n",
            "Downloading pip-25.0-py3-none-any.whl (1.8 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.8/1.8 MB\u001b[0m \u001b[31m17.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pip\n",
            "  Attempting uninstall: pip\n",
            "    Found existing installation: pip 24.1.2\n",
            "    Uninstalling pip-24.1.2:\n",
            "      Successfully uninstalled pip-24.1.2\n",
            "Successfully installed pip-25.0\n",
            "Requirement already satisfied: pdfplumber in /usr/local/lib/python3.11/dist-packages (0.11.5)\n",
            "Requirement already satisfied: transformers in /usr/local/lib/python3.11/dist-packages (4.48.2)\n",
            "Requirement already satisfied: spacy in /usr/local/lib/python3.11/dist-packages (3.7.5)\n",
            "Requirement already satisfied: scikit-learn in /usr/local/lib/python3.11/dist-packages (1.6.1)\n",
            "Requirement already satisfied: datasets in /usr/local/lib/python3.11/dist-packages (3.2.0)\n",
            "Requirement already satisfied: nltk in /usr/local/lib/python3.11/dist-packages (3.9.1)\n",
            "Requirement already satisfied: pdfminer.six==20231228 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (20231228)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (11.1.0)\n",
            "Requirement already satisfied: pypdfium2>=4.18.0 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (4.30.1)\n",
            "Requirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (3.4.1)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.11/dist-packages (from transformers) (3.17.0)\n",
            "Requirement already satisfied: huggingface-hub<1.0,>=0.24.0 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.28.1)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.11/dist-packages (from transformers) (1.26.4)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from transformers) (24.2)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.11/dist-packages (from transformers) (6.0.2)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.11/dist-packages (from transformers) (2024.11.6)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.11/dist-packages (from transformers) (2.32.3)\n",
            "Requirement already satisfied: tokenizers<0.22,>=0.21 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.21.0)\n",
            "Requirement already satisfied: safetensors>=0.4.1 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.5.2)\n",
            "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.11/dist-packages (from transformers) (4.67.1)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.12)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.11)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.5.1)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.15.1)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.10.6)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.1.5)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.11/dist-packages (from spacy) (75.1.0)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.5.0)\n",
            "Requirement already satisfied: scipy>=1.6.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (1.13.1)\n",
            "Requirement already satisfied: joblib>=1.2.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (1.4.2)\n",
            "Requirement already satisfied: threadpoolctl>=3.1.0 in /usr/local/lib/python3.11/dist-packages (from scikit-learn) (3.5.0)\n",
            "Requirement already satisfied: pyarrow>=15.0.0 in /usr/local/lib/python3.11/dist-packages (from datasets) (17.0.0)\n",
            "Requirement already satisfied: dill<0.3.9,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from datasets) (0.3.8)\n",
            "Requirement already satisfied: pandas in /usr/local/lib/python3.11/dist-packages (from datasets) (2.2.2)\n",
            "Requirement already satisfied: xxhash in /usr/local/lib/python3.11/dist-packages (from datasets) (3.5.0)\n",
            "Requirement already satisfied: multiprocess<0.70.17 in /usr/local/lib/python3.11/dist-packages (from datasets) (0.70.16)\n",
            "Requirement already satisfied: fsspec<=2024.9.0,>=2023.1.0 in /usr/local/lib/python3.11/dist-packages (from fsspec[http]<=2024.9.0,>=2023.1.0->datasets) (2024.9.0)\n",
            "Requirement already satisfied: aiohttp in /usr/local/lib/python3.11/dist-packages (from datasets) (3.11.11)\n",
            "Requirement already satisfied: click in /usr/local/lib/python3.11/dist-packages (from nltk) (8.1.8)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (2.4.4)\n",
            "Requirement already satisfied: aiosignal>=1.1.2 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (1.3.2)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (25.1.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (1.5.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (6.1.0)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (0.2.1)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets) (1.18.3)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.24.0->transformers) (4.12.2)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.11/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.2 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (2.27.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests->transformers) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests->transformers) (2.3.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests->transformers) (2025.1.31)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.11/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.11/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.1.5)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.11/dist-packages (from jinja2->spacy) (3.0.2)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets) (2.8.2)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets) (2025.1)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets) (2025.1)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.11/dist-packages (from cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (1.17.1)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy) (1.2.1)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.11/dist-packages (from python-dateutil>=2.8.2->pandas->datasets) (1.17.0)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.11/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy) (1.17.2)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.11/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (2.22)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.11/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (0.1.2)\n",
            "Collecting en-core-web-sm==3.7.1\n",
            "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_sm-3.7.1/en_core_web_sm-3.7.1-py3-none-any.whl (12.8 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.8/12.8 MB\u001b[0m \u001b[31m29.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.8.0,>=3.7.2 in /usr/local/lib/python3.11/dist-packages (from en-core-web-sm==3.7.1) (3.7.5)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.12)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.11)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.5.1)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.15.1)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.67.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.10.6)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.1.5)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.26.4)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.11/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.2 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.27.2)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.4.1)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.3.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2025.1.31)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.11/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.11/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.1.8)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.11/dist-packages (from jinja2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.11/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.17.2)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.11/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.2)\n",
            "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
            "You can now load the package via spacy.load('en_core_web_sm')\n",
            "\u001b[38;5;3m⚠ Restart to reload dependencies\u001b[0m\n",
            "If you are in a Jupyter or Colab notebook, you may need to restart Python in\n",
            "order to load all the package's dependencies. You can do this by selecting the\n",
            "'Restart kernel' or 'Restart runtime' option.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import torch\n",
        "from transformers import BertTokenizer, BertForSequenceClassification, Trainer, TrainingArguments"
      ],
      "metadata": {
        "id": "e0VkZHtQ46xp"
      },
      "execution_count": 20,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import torch\n",
        "from transformers import BertTokenizer, BertForSequenceClassification, Trainer, TrainingArguments\n",
        "\n",
        "tokenizer = BertTokenizer.from_pretrained('bert-base-uncased')\n",
        "\n",
        "def tokenize_function(text):\n",
        "    return tokenizer(text, padding=\"max_length\", truncation=True, return_tensors=\"pt\")\n",
        "\n",
        "# Tokenize the text\n",
        "inputs = tokenize_function(preprocessed_text)\n",
        "\n",
        "# Add dummy labels\n",
        "labels = torch.tensor([1] * inputs['input_ids'].shape[0])\n",
        "\n",
        "# Convert inputs to Dataset format\n",
        "class CustomDataset(torch.utils.data.Dataset):\n",
        "    def __init__(self, encodings, labels):\n",
        "        self.encodings = encodings\n",
        "        self.labels = labels\n",
        "\n",
        "    def __getitem__(self, idx):\n",
        "        item = {key: val[idx] for key, val in self.encodings.items()}\n",
        "        item['labels'] = self.labels[idx]\n",
        "        return item\n",
        "\n",
        "    def __len__(self):\n",
        "        return len(self.labels)\n",
        "\n",
        "dataset = CustomDataset(inputs, labels)\n",
        "\n",
        "# Fine-tune the model\n",
        "model = BertForSequenceClassification.from_pretrained('bert-base-uncased', num_labels=2)\n",
        "\n",
        "training_args = TrainingArguments(\n",
        "    output_dir='./results',\n",
        "    eval_strategy=\"no\",  # Set evaluation strategy to 'no'\n",
        "    learning_rate=2e-5,\n",
        "    per_device_train_batch_size=8,\n",
        "    per_device_eval_batch_size=8,\n",
        "    num_train_epochs=3,\n",
        "    weight_decay=0.01,\n",
        "    report_to=\"none\"  # Disable wandb logging\n",
        ")\n",
        "\n",
        "trainer = Trainer(\n",
        "    model=model,\n",
        "    args=training_args,\n",
        "    train_dataset=dataset,\n",
        ")\n",
        "\n",
        "trainer.train()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 148
        },
        "id": "WKX0NJNO8AEZ",
        "outputId": "913e644d-39bf-4eca-8553-273702df495a"
      },
      "execution_count": 26,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Some weights of BertForSequenceClassification were not initialized from the model checkpoint at bert-base-uncased and are newly initialized: ['classifier.bias', 'classifier.weight']\n",
            "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='3' max='3' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [3/3 00:22, Epoch 3/3]\n",
              "    </div>\n",
              "    <table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              " <tr style=\"text-align: left;\">\n",
              "      <th>Step</th>\n",
              "      <th>Training Loss</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "  </tbody>\n",
              "</table><p>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "TrainOutput(global_step=3, training_loss=0.4872499306996663, metrics={'train_runtime': 36.9527, 'train_samples_per_second': 0.081, 'train_steps_per_second': 0.081, 'total_flos': 789333166080.0, 'train_loss': 0.4872499306996663, 'epoch': 3.0})"
            ]
          },
          "metadata": {},
          "execution_count": 26
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "inputs = tokenizer(preprocessed_text, return_tensors=\"pt\", padding=True, truncation=True)\n",
        "outputs = model(**inputs)\n",
        "logits = outputs.logits\n",
        "\n",
        "# Get the number of available predictions\n",
        "num_predictions = logits.size(1)\n",
        "\n",
        "# Request top k items based on the available number of predictions\n",
        "predicted_class = torch.topk(logits, min(10, num_predictions)).indices.tolist()\n"
      ],
      "metadata": {
        "id": "_bozwVbb9_hs"
      },
      "execution_count": 28,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(document_text)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_0eVxJZ5-Q0t",
        "outputId": "166eeada-bc6e-41be-9705-b20d55ebe424"
      },
      "execution_count": 29,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 1 of 26 PageID 3760\n",
            "UNITED STATES DISTRICT COURT\n",
            "NORTHERN DISTRICT OF TEXAS\n",
            "AMARILLO DIVISION\n",
            "ALLIANCE FOR HIPPOCRATIC\n",
            "MEDICINE, et al.,\n",
            "Plaintiffs,\n",
            "v. Case No. 2:22-cv-00223-Z\n",
            "U.S. FOOD AND DRUG\n",
            "ADMINISTRATION, et al.,\n",
            "Defendants.\n",
            "AMICUS CURIAE BRIEF OF MISSISSIPPI, ALABAMA, ALASKA,\n",
            "ARKANSAS, FLORIDA, GEORGIA, IDAHO, INDIANA, IOWA, KANSAS,\n",
            "KENTUCKY, LOUISIANA, MONTANA, NEBRASKA, OHIO, OKLAHOMA,\n",
            "SOUTH CAROLINA, SOUTH DAKOTA, TENNESSEE, TEXAS, UTAH, AND\n",
            "WYOMING IN SUPPORT OF PLAINTIFFS’ MOTION\n",
            "FOR PRELIMINARY INJUNCTIONCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 2 of 26 PageID 3761\n",
            "TABLE OF CONTENTS\n",
            "Page\n",
            "TABLE OF AUTHORITIES .......................................................................................... ii\n",
            "INTRODUCTION, INTEREST OF AMICI CURIAE,\n",
            "AND SUMMARY OF ARGUMENT .............................................................................. 1\n",
            "BACKGROUND ............................................................................................................. 4\n",
            "ARGUMENT .................................................................................................................. 7\n",
            "The Public Interest And Equities Support Injunctive Relief Against The FDA’s\n",
            "Actions On Mifepristone ........................................................................................ 7\n",
            "A. The Public Interest And Equities Weigh Strongly Against The FDA’s Actions\n",
            "Because Those Actions Defy Federal Law ....................................................... 8\n",
            "B. The FDA’s Actions Undermine The Public-Interest Determinations That\n",
            "States—Not Federal Agencies—Are Entitled To Make ................................ 11\n",
            "C. The FDA’s Actions Harm The Public Interest By Undermining States’ Ability\n",
            "To Protect Their Citizens And Forcing States To Divert Scarce Resources To\n",
            "Investigating And Prosecuting Violations Of Their Laws ............................ 14\n",
            "CONCLUSION ............................................................................................................. 18\n",
            "iCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 3 of 26 PageID 3762\n",
            "TABLE OF AUTHORITIES\n",
            "Page(s)\n",
            "Cases\n",
            "Dobbs v. Jackson Women’s Health Organization,\n",
            "142 S. Ct. 2228 (2022) ............................................................ 1, 2, 11, 12, 13, 14, 17\n",
            "Gonzales v. Oregon,\n",
            "546 U.S. 243 (2006) ................................................................................................ 12\n",
            "Hillsborough Cnty., Fla. v. Automated Med. Laboratories, Inc.,\n",
            "471 U.S. 707 (1985) ................................................................................................ 12\n",
            "Maine v. Taylor,\n",
            "477 U.S. 131 (1986) ................................................................................................ 16\n",
            "Metro. Life Ins. Co. v. Massachusetts,\n",
            "471 U.S. 724 (1985) .......................................................................................... 12, 15\n",
            "Rice v. Santa Fe Elevator Corp.,\n",
            "331 U.S. 218 (1947) ................................................................................................ 15\n",
            "Solid Waste Agency of N. Cook Cnty. v. U.S. Army Corps of Engineers,\n",
            "531 U.S. 159 (2001) ................................................................................................ 15\n",
            "Texas v. Biden,\n",
            "10 F.4th 538 (5th Cir. 2021) ............................................................................... 8, 11\n",
            "Texas v. United States,\n",
            "787 F.3d 733 (5th Cir. 2015) ............................................................................. 16-17\n",
            "Valley v. Rapides Parish Sch. Bd.,\n",
            "118 F.3d 1047 (5th Cir. 1997) ............................................................................ 8, 11\n",
            "Wages & White Lion Invs., LLC v. FDA,\n",
            "16 F.4th 1130 (5th Cir. 2021) ................................................................................... 8\n",
            "Constitutional Provision\n",
            "U.S. Const. amend. X ................................................................................................... 14\n",
            "iiCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 4 of 26 PageID 3763\n",
            "Statutes\n",
            "18 U.S.C. § 1461 ............................................................................................... 10, 11, 14\n",
            "18 U.S.C. § 1462 ..................................................................................................... 10, 11\n",
            "21 U.S.C. § 321 ............................................................................................................... 4\n",
            "21 U.S.C. § 355 ............................................................................................................... 4\n",
            "21 U.S.C. § 355-1............................................................................................................ 5\n",
            "21 U.S.C. § 393 ............................................................................................................... 4\n",
            "Food and Drug Administration Amendments Act,\n",
            "Pub. L. No. 110-85, 121 Stat. 823 (2007) ............................................................. 5, 9\n",
            "Ind. Code Ann. § 16-34-2-1 .......................................................................................... 13\n",
            "La. Stat. Ann. § 40:1061.11 ......................................................................................... 13\n",
            "Miss. Code Ann. § 41-41-45 ................................................................................... 12, 13\n",
            "Miss. Code Ann. § 41-41-103 ....................................................................................... 13\n",
            "Miss. Code Ann. § 41-41-107 ....................................................................................... 13\n",
            "Okla. Stat. Ann. tit. 63, § 1-729.1 ............................................................................... 13\n",
            "Pub. L. No. 91-662, 84 Stat. 1973 (1971) .................................................................... 10\n",
            "Tex. Health & Safety Code Ann. § 171.063 ................................................................ 13\n",
            "Executive Order\n",
            "Protecting Access to Reproductive Healthcare Services,\n",
            "Exec. Order No. 14076,\n",
            "87 Fed. Reg. 42053 (2022) .................................................................................. 2, 11\n",
            "Regulations\n",
            "21 C.F.R. § 314.2 ..................................................................................................... 13-14\n",
            "21 C.F.R. § 314.500 ............................................................................... 4, 8, 9, 10, 13-14\n",
            "iiiCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 5 of 26 PageID 3764\n",
            "21 C.F.R. § 314.520 ........................................................................................................ 4\n",
            "21 C.F.R. §§ 314.500-314.560 ........................................................................................ 5\n",
            "Rulemaking\n",
            "New Drug, Antibiotic, and Biological Drug Product Regulations;\n",
            "Accelerated Approval,\n",
            "57 Fed. Reg. 58942 (Dec. 11, 1992) .......................................................................... 9\n",
            "Other Authorities\n",
            "Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says,\n",
            "N.Y. Times (Jan. 3, 2023) ....................................................................................... 16\n",
            "Fact Sheet: President Biden Announces Actions In Light of\n",
            "Today’s Supreme Court Decision on Dobbs v. Jackson\n",
            "Women’s Health Organization,\n",
            "The White House (June 24, 2022) ............................................................................ 2\n",
            "Fact Sheet: President Biden to Sign Presidential Memorandum\n",
            "on Ensuring Safe Access to Medication Abortion,\n",
            "The White House (Jan. 22, 2023) ............................................................................. 2\n",
            "H.R. 13959, 95th Cong. (1978) .................................................................................... 10\n",
            "H.R. Rep. No. 29 (1979) ............................................................................................... 10\n",
            "Memorandum on Further Efforts to Protect Access to\n",
            "Reproductive Healthcare Services,\n",
            "The White House (Jan. 22, 2023) ................................................................. 2, 15, 17\n",
            "NIH, Nat’l Library of Medicine ..................................................................................... 4\n",
            "Remarks of President Joe Biden—State of the Union Address\n",
            "as Prepared for Delivery,\n",
            "The White House (Feb. 7, 2023) ............................................................................. 17\n",
            "Retail Pharmacies Can Now Offer Abortion Pill, FDA Says,\n",
            "Politico (Jan. 3, 2023) ............................................................................................. 16\n",
            "U.S. Food & Drug Admin.,\n",
            "Information about Mifepristone for Medical Termination of\n",
            "Pregnancy Through Ten Weeks Gestation ........................................................... 6-7\n",
            "ivCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 6 of 26 PageID 3765\n",
            "U.S. Food & Drug Admin.,\n",
            "Risk Evaluation and Mitigation Strategies ............................................................. 5\n",
            "vCase 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 7 of 26 PageID 3766\n",
            "INTRODUCTION, INTEREST OF AMICI CURIAE,\n",
            "AND SUMMARY OF ARGUMENT\n",
            "Last year, the Supreme Court held that abortion is a matter that is entrusted\n",
            "to “the people and their elected representatives” to address. Dobbs v. Jackson\n",
            "Women’s Health Organization, 142 S. Ct. 2228, 2284 (2022). Overruling precedent\n",
            "that took that authority away from the people, the Court returned the issue of\n",
            "“regulating or prohibiting abortion” to “the citizens of each State.” Ibid. States may\n",
            "thus pursue their “legitimate interests” in protecting unborn life, women’s health,\n",
            "and the medical profession’s integrity by regulating or restricting abortion. Ibid.\n",
            "Amici curiae are the States of Mississippi, Alabama, Alaska, Arkansas,\n",
            "Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Montana,\n",
            "Nebraska, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah,\n",
            "and Wyoming. Like other States, amici have, consistent with the Constitution and\n",
            "the Supreme Court’s decision in Dobbs, adopted laws regulating abortion—including\n",
            "chemical abortion. Those laws strike a balance among the competing interests, are\n",
            "the results of hard-fought democratic processes, and embody the considered\n",
            "judgments of “the people and their elected representatives.” Ibid. Some States have\n",
            "chosen to adopt or maintain tighter restrictions and more thorough regulations on\n",
            "abortion after Dobbs. Other States have continued or embraced more permissive\n",
            "regimes. All States have provisions in their abortion laws to protect a woman’s life\n",
            "and commonly include exceptions in other circumstances. These choices reflect the\n",
            "approach the Constitution envisions for addressing complex issues that require\n",
            "“legislative bodies” to “draw lines that accommodate competing interests.” Id. at 2268.\n",
            "1Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 8 of 26 PageID 3767\n",
            "Rather than respect the Constitution, the Supreme Court, and the democratic\n",
            "process, the Biden Administration has attacked and worked to undermine the\n",
            "considered judgments of the elected representatives of States like amici. The\n",
            "Administration’s actions on abortion drugs typify that effort. The day Dobbs was\n",
            "decided, President Biden directed his Administration to ensure that abortion drugs\n",
            "are “as widely accessible as possible,” including “through telehealth and sent by\n",
            "mail.” Fact Sheet: President Biden Announces Actions In Light of Today’s Supreme\n",
            "Court Decision on Dobbs v. Jackson Women’s Health Organization, The White House\n",
            "(June 24, 2022), http://bit.ly/3DqTmwd. The President soon signed an executive order\n",
            "lamenting States’ regulation of abortion and directing federal agencies to “expand\n",
            "access to abortion care, including medication abortion.” Protecting Access to\n",
            "Reproductive Healthcare Services, Exec. Order No. 14076, 87 Fed. Reg. 42053, 42053\n",
            "(2022). Just weeks ago, President Biden signed a memorandum spotlighting his\n",
            "Administration’s efforts to “evaluat[e] and monitor[ ]” state laws “that threaten to\n",
            "infringe” on purported “Federal legal protections [for abortion].” Memorandum on\n",
            "Further Efforts to Protect Access to Reproductive Healthcare Services, The White\n",
            "House (Jan. 22, 2023), http://bit.ly/3kEZrPl. He also expressed his intent to promote\n",
            "access to abortion drugs for patients and providers “no matter where they live.” Fact\n",
            "Sheet: President Biden to Sign Presidential Memorandum on Ensuring Safe Access\n",
            "to Medication Abortion, The White House (Jan. 22, 2023), http://bit.ly/3I160Vn.\n",
            "Although the Biden Administration has, following Dobbs, doubled down on its\n",
            "efforts to impose on the country an elective-abortion policy that it could never achieve\n",
            "through the democratic process, that goal is not new—especially with abortion drugs.\n",
            "2Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 9 of 26 PageID 3768\n",
            "For two decades, the U.S. Food and Drug Administration has acted to establish a\n",
            "nationwide regime of on-demand abortion by licensing sweeping access to chemical\n",
            "abortion drugs—in defiance of federal and state laws protecting life, health, and\n",
            "safety. See Pls.’ Mot. 2-6, Dkt. 7. In 2000, the FDA purported to approve the drug\n",
            "mifepristone for chemically induced abortions through 49 days of pregnancy. That\n",
            "approval had basic legal problems of its own, but it did include safety measures to\n",
            "account for mifepristone’s serious risks to life and health. Yet over time the FDA has\n",
            "cast even those measures aside. In 2016, the FDA rolled back many safety\n",
            "requirements—allowing mifepristone to be prescribed later in pregnancy, by non-\n",
            "doctors, and with only one in-person visit. In 2021, the agency halted the remaining\n",
            "in-person dispensing requirements during the COVID-19 pandemic and later\n",
            "abandoned the requirements altogether. After decades of such efforts, the FDA now\n",
            "broadly condones a wide-ranging mail-order abortion-drug regime. Plaintiffs here\n",
            "have moved to preliminarily enjoin and set aside the FDA’s actions.\n",
            "This brief explains why the public interest and equities strongly support relief\n",
            "against the FDA’s actions. First, the FDA’s actions contravene federal law and so\n",
            "disserve the public interest. Second, the FDA’s actions defy the public-interest\n",
            "determinations made by the amici States, which are entrusted with balancing the\n",
            "policy and equitable considerations in this area. Last, the FDA’s actions threaten to\n",
            "undermine the amici States’ enforcement of duly enacted laws and thus undercut the\n",
            "public interest that those laws promote. For these reasons, injunctive relief against\n",
            "the FDA’s actions would promote the public interest.\n",
            "3Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 10 of 26 PageID 3769\n",
            "BACKGROUND\n",
            "The Federal Food, Drug, and Cosmetic Act directs the U.S. Food and Drug\n",
            "Administration to “protect the public health by ensuring that ... human and\n",
            "veterinary drugs are safe and effective.” 21 U.S.C. § 393(b)(2)(B). Under the Act, the\n",
            "FDA is responsible for approving any “new drug” before it is marketed and distributed\n",
            "to the public. Id. § 321(p)(1). The Act bars anyone from “introduc[ing] or deliver[ing]\n",
            "for introduction into interstate commerce any new drug” without FDA “approval.” Id.\n",
            "§ 355(a). To obtain FDA approval, a new drug must undergo an extensive process\n",
            "with rigorous testing. The FDA’s conclusion that a drug is safe and effective must be\n",
            "based on “substantial evidence” of expert consensus. Id. § 355(d).\n",
            "In 2000, the FDA approved the marketing and distribution of mifepristone for\n",
            "“the medical termination of intrauterine pregnancy through 49 days’ pregnancy.”\n",
            "App.518, Dkt. 8. Mifepristone is a synthetic steroid that causes “menstrual bleeding,\n",
            "disruption of the endometrium [or uterine lining], and then termination” of a\n",
            "pregnancy. Mifepristone, NIH, Nat’l Library of Medicine, http://bit.ly/403EjSN.\n",
            "Mifepristone is generally followed by a dose of misoprostol, which causes the pregnant\n",
            "woman’s uterus to contract and expel the detached embryo. Id., Misoprostol,\n",
            "http://bit.ly/3DgTpKZ.\n",
            "The FDA approved mifepristone under Subpart H of the agency’s regulations,\n",
            "which implement the agency’s general authority to approve new drugs that “have\n",
            "been studied for their safety and effectiveness in treating serious or life-threatening\n",
            "illnesses,” 21 C.F.R. § 314.500, and “can be safely used only if distribution or use is\n",
            "restricted,” id. § 314.520. To satisfy Subpart H, the FDA needed to—and did—deem\n",
            "4Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 11 of 26 PageID 3770\n",
            "pregnancy a “serious or life-threatening illness[ ]” (even in the absence of\n",
            "complications) and conclude that mifepristone was “safe[ ]” and “provide[d]\n",
            "meaningful therapeutic benefit.” App.523 (citing 21 C.F.R. §§ 314.500-314.560).\n",
            "Despite approving mifepristone, the FDA recognized the serious risk of “urgent\n",
            "adverse event[s] associated with” the drug—including incomplete abortions or severe\n",
            "bleeding requiring surgery. App.522. These risks increase later in pregnancy and in\n",
            "cases of ectopic pregnancy. App.518-25, 607-09. The approval thus included\n",
            "requirements that the drug be provided only “by or under the supervision of a\n",
            "physician” with the ability to “assess the duration of pregnancy accurately,” “diagnose\n",
            "ectopic pregnancies,” “provide [or arrange for] surgical intervention in cases of\n",
            "incomplete abortion or severe bleeding,” and “assure patient access to medical\n",
            "facilities equipped to provide blood transfusions and resuscitation.” App.523.\n",
            "In 2007, Congress enacted the Food and Drug Administration Amendments\n",
            "Act, Pub. L. No. 110-85, 121 Stat. 823 (2007). That law affected FDA approvals under\n",
            "Subpart H. It directed the agency to adopt a Risk Evaluation and Mitigation Strategy\n",
            "(REMS) for a new drug when “necessary to ensure that the benefits of the drug\n",
            "outweigh the risks.” 21 U.S.C. § 355-1(a)(1)-(2). A REMS operates as a “drug safety\n",
            "program” for medications that present “serious safety concerns.” U.S. Food & Drug\n",
            "Admin., Risk Evaluation and Mitigation Strategies, http://bit.ly/3wKOwGp; see ibid.\n",
            "(“While all medications have labeling that informs health care stakeholders about\n",
            "medication risks, only a few medications require a REMS.”). Because of the serious\n",
            "safety concerns involved, the FDA established a REMS program for mifepristone in\n",
            "2011 with various “elements to assure safe use,” including a requirement that the\n",
            "5Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 12 of 26 PageID 3771\n",
            "drug be dispensed only in certain healthcare settings—clinics, medical offices, and\n",
            "hospitals—under the supervision of a certified prescriber. App.731-32.\n",
            "Despite the risks that the FDA itself recognized, over the next decade and\n",
            "beyond, the Obama and Biden Administrations expanded mifepristone’s use and\n",
            "dropped the safety measures erected around it. In 2016, the FDA extended the\n",
            "approved use of mifepristone through 70 days (10 weeks) of pregnancy, allowed a\n",
            "broader set of persons to prescribe the drug, and reduced the number of required in-\n",
            "person patient visits from three to one. App.625-52, 732. But the agency maintained\n",
            "the requirement for at least one in-person visit so that the drug could be dispensed\n",
            "only in clinics, medical offices, and hospitals under the supervision of a certified\n",
            "healthcare provider. App.733.\n",
            "In April 2021, however, the FDA stopped enforcing the in-person-dispensing\n",
            "requirements. The FDA attributed that decision to “COVID-related risks” of in-\n",
            "person dispensing. App.715. The agency added that it would “exercise enforcement\n",
            "discretion during the COVID-19 [public-health emergency] with respect to the\n",
            "dispensing of mifepristone through the mail.” Ibid.\n",
            "In December 2021, the FDA abandoned the in-person dispensing requirement\n",
            "altogether. App.735. It made this decision independent of any COVID-related risks\n",
            "and despite recognizing that “certain elements of the Mifepristone REMS Program”—\n",
            "including “healthcare provider certification and dispensing of mifepristone to\n",
            "patients with evidence or other documentation of safe use conditions”—“remain\n",
            "necessary to assure the safe use of mifepristone” and “ensure the benefits of\n",
            "mifepristone outweigh the risks.” Ibid. On January 3, 2023, the FDA modified the\n",
            "6Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 13 of 26 PageID 3772\n",
            "mifepristone REMS program to make clear the agency’s position that the drug can\n",
            "now be dispensed by certified prescribers or retail pharmacies “in-person or by mail.”\n",
            "U.S. Food & Drug Admin., Information about Mifepristone for Medical Termination\n",
            "of Pregnancy Through Ten Weeks Gestation, http://bit.ly/3kHmh8Q.\n",
            "While the FDA is authorized to evaluate new drugs for safety and effectiveness,\n",
            "States are primarily responsible for protecting the health and welfare of their\n",
            "citizens. Many States, including several amici here, have thus enacted laws to\n",
            "regulate abortion-inducing drugs and account for their dangers. Such laws can\n",
            "include in-person examination and dispensing requirements, qualification\n",
            "requirements for prescribers, mandates for informed consent, bans on distribution by\n",
            "mailing, or some combination of these and other safety limitations. See infra.\n",
            "The lawsuit here seeks to enjoin the panoply of agency actions through which\n",
            "the FDA has approved mifepristone, made it widely accessible, and discarded\n",
            "measures to manage the risks that it presents.\n",
            "ARGUMENT\n",
            "The Public Interest And Equities Support Injunctive Relief Against\n",
            "The FDA’s Actions On Mifepristone.\n",
            "The FDA’s challenged actions on mifepristone are deeply flawed. They defy\n",
            "federal law, flout the public-interest determinations that States have properly made,\n",
            "and undermine the public interest in the enforcement of validly enacted state laws.\n",
            "These features strongly support injunctive relief against the agency’s actions.\n",
            "7Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 14 of 26 PageID 3773\n",
            "A. The Public Interest And Equities Weigh Strongly Against The\n",
            "FDA’s Actions Because Those Actions Defy Federal Law.\n",
            "Plaintiffs have demonstrated that the FDA’s actions on mifepristone violate\n",
            "the Federal Food, Drug, and Cosmetic Act and related FDA regulations. See Pls.’ Mot.\n",
            "14-23. Amici emphasize that the FDA’s actions defy both the agency’s regulations and\n",
            "also federal laws restricting the mailing of abortion drugs. The public interest and\n",
            "equities thus favor injunctive relief against the FDA’s actions.\n",
            "An agency action defies the public interest if it is unlawful. “There is generally\n",
            "no public interest in the perpetuation of unlawful agency action.” Texas v. Biden,\n",
            "10 F.4th 538, 560 (5th Cir. 2021) (brackets omitted); see also Wages & White Lion\n",
            "Invs., LLC v. FDA, 16 F.4th 1130, 1143 (5th Cir. 2021). Allowing illegal actions by\n",
            "government agencies to stand “undermine[s]” the public interest. Valley v. Rapides\n",
            "Parish Sch. Bd., 118 F.3d 1047, 1056 (5th Cir. 1997). And there is a strong public\n",
            "interest “in having governmental agencies abide by the federal laws that govern their\n",
            "existence and operations.” Biden, 10 F.4th at 559.\n",
            "The FDA’s actions here have two basic legal flaws.\n",
            "First, the FDA’s approval of mifepristone defies the agency’s own regulations.\n",
            "As noted, the agency relied on Subpart H of its regulations when it first approved\n",
            "mifepristone in 2000. Subpart H permits the FDA to approve “certain new drug\n",
            "products that have been studied for their safety and effectiveness in treating serious\n",
            "or life-threatening illnesses and that provide meaningful therapeutic benefit to\n",
            "patients over existing treatments.” 21 C.F.R. § 314.500 (emphasis added). That\n",
            "regulation doubly forecloses the FDA’s approval. Pregnancy is not an “illness[ ].” It is\n",
            "a natural state essential to perpetuating human life. And typical early-stage\n",
            "8Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 15 of 26 PageID 3774\n",
            "pregnancy without complications is not a condition that is “serious or life-\n",
            "threatening” or that requires the “treatment” mifepristone provides.\n",
            "The FDA admits that pregnancy is not an illness but claims that its\n",
            "rulemaking “explained that Subpart H was available for serious or life-threatening\n",
            "‘conditions,’ whether or not they were understood colloquially to be ‘illnesses.’” Opp.\n",
            "26, Dkt. 28 (quoting New Drug, Antibiotic, and Biological Drug Product Regulations;\n",
            "Accelerated Approval, 57 Fed. Reg. 58942, 58946 (Dec. 11, 1992)). But an\n",
            "unambiguous regulation—not the agency’s aspirational gloss on it—controls. As\n",
            "explained, that clear regulatory text defeats the FDA’s view and thus its approval of\n",
            "mifepristone. At most, the FDA’s argument suggests that it could have approved\n",
            "mifepristone under Subpart H for cases in which a pregnant woman’s life or health\n",
            "is seriously in danger. That is not what it did—and the FDA still would have been\n",
            "stuck with the reality that pregnancy is not an “illness[ ].” 21 C.F.R. § 314.500.\n",
            "Subpart H does not permit the agency to greenlight elective abortions on a wide scale.\n",
            "The FDA also claims that “any hypothetical error in the initial reliance on\n",
            "Subpart H” has “been overtaken by congressional action.” Opp. 25, 26. This is not the\n",
            "argument of an agency that is confident in the legality of its actions. And the\n",
            "argument fails. When Congress established the REMS framework in 2007, it\n",
            "temporarily “deemed to have in effect an approved risk evaluation and mitigation\n",
            "strategy” any “drug that was [previously] approved” under Subpart H with “elements\n",
            "to assure safe use,” Pub. L. No. 110-85, § 909(b)(1), 121 Stat. at 950, and required the\n",
            "sponsors of such drugs to “submit to the [FDA] a proposed risk evaluation and\n",
            "mitigation strategy” within 180 days, id. § 909(b)(3), 121 Stat. at 951. This means\n",
            "9Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 16 of 26 PageID 3775\n",
            "that Congress “deemed” preexisting safety requirements to be sufficient REMS\n",
            "programs under the new 2007 law until a new strategy was approved. That law did\n",
            "not affect whether a drug was properly authorized under Subpart H in the first place\n",
            "to treat “serious or life-threatening illnesses.” 21 C.F.R. § 314.500. Congressional\n",
            "action did not blot out the FDA’s defiance of its own regulation.\n",
            "Second, the FDA’s actions defy federal criminal law. Longstanding federal law\n",
            "provides that “[e]very article or thing designed, adapted, or intended for producing\n",
            "abortion ... [i]s declared to be nonmailable matter and shall not be conveyed in the\n",
            "mails or delivered from any post office or by any letter carrier.” 18 U.S.C. § 1461. A\n",
            "related statute makes it a federal crime to “knowingly use[ ] any express company or\n",
            "other common carrier” to ship “in interstate or foreign commerce ... any drug,\n",
            "medicine, article, or thing designed, adapted, or intended for producing abortion.” Id.\n",
            "§ 1462. Violations of either statute are punishable by five or more years of\n",
            "imprisonment. Id. §§ 1461, 1462. These statutes prohibit using the mail to send or\n",
            "receive abortion-inducing drugs such as mifepristone. The statutes’ restrictions on\n",
            "abortion have remained in place—even as Congress has repealed other parts of these\n",
            "laws. See Pub. L. No. 91-662, 84 Stat. 1973 (1971) (repealing certain restrictions on\n",
            "contraceptives from what is now section 1461). Congress has also considered\n",
            "narrowing those statutes with a targeted intent requirement. See H.R. 13959, 95th\n",
            "Cong. §§ 6701(a)(1)(2), 6702(1)(C)(i) (1978); see also H.R. Rep. No. 29, pt. 3, at 42\n",
            "(1979) (explaining how bill would have “change[d] current law”). Those efforts failed.\n",
            "A late-breaking memo from the Biden Justice Department, see Application of the\n",
            "Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions,\n",
            "10Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 17 of 26 PageID 3776\n",
            "46 Op. OLC __ (Dec. 23, 2022), reads into sections 1461 and 1462 the very intent\n",
            "requirement that Congress refused to enact. But that memo cannot paper over clear\n",
            "statutory language or the historical reality that Congress has not altered the relevant\n",
            "text.\n",
            "The FDA’s challenged actions on mifepristone thus defy the agency’s\n",
            "regulatory authority and longstanding federal criminal law. Because those actions\n",
            "are at war with the law, the FDA cannot claim any public interest in enforcing them.\n",
            "Indeed, enjoining the FDA to “abide by” federal law would promote the public\n",
            "interest, Biden, 10 F.4th at 559—and not issuing injunctive relief would “undermine”\n",
            "the public interest, Valley, 118 F.3d at 1056.\n",
            "B. The FDA’s Actions Undermine The Public-Interest\n",
            "Determinations That States—Not Federal Agencies—Are\n",
            "Entitled To Make.\n",
            "The FDA was not responding to changed circumstances on the safety of\n",
            "mifepristone when it cast aside the longstanding requirements for in-person\n",
            "dispensing. Nor was the agency following any legislative mandate from Congress\n",
            "when promoting a new mail-order abortion regime. Rather, the agency was acting at\n",
            "the behest of the Biden Administration and its allies who demanded political action\n",
            "after Dobbs. After that decision the Administration swiftly declared that duly enacted\n",
            "state laws on abortion will have “devastating implications” for “public health” and\n",
            "that the federal government would act to “expand access to abortion care, including\n",
            "medication abortion,” Protecting Access to Reproductive Healthcare Services, Exec.\n",
            "Order No. 14076, 87 Fed. Reg. 42053, 42053 (2022)—despite considered judgments\n",
            "by elected representatives on how to address the health interests at stake. But, as\n",
            "11Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 18 of 26 PageID 3777\n",
            "the Supreme Court recognized, it is the responsibility of elected representatives in\n",
            "States—not unelected bureaucrats in federal agencies—to strike the balance between\n",
            "“competing interests” on abortion. Dobbs, 142 S. Ct. at 2268. The FDA’s actions seek\n",
            "to override the balance properly struck by States. If allowed to stand, those actions\n",
            "will harm the public interest.\n",
            "Under our Constitution, States have the primary authority to legislate to\n",
            "protect the health, safety, and welfare of their citizens. Hillsborough Cnty., Fla. v.\n",
            "Automated Med. Laboratories, Inc., 471 U.S. 707, 719 (1985) (“[T]he regulation of\n",
            "health and safety matters is primarily, and historically, a matter of local concern.”);\n",
            "Metro. Life Ins. Co. v. Massachusetts, 471 U.S. 724, 756 (1985) (“The States\n",
            "traditionally have had great latitude under their police powers to legislate as to the\n",
            "protection of the lives, limbs, health, comfort, and quiet of all persons.”) (internal\n",
            "quotation marks omitted). This power includes regulating the medical profession and\n",
            "setting standards of care. Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (“[A]\n",
            "functioning medical profession [is] regulated under the States’ police powers.”).\n",
            "Using this authority, States have adopted varying approaches to abortion that\n",
            "reflect the policy decisions of their constituent citizens. State laws restricting abortion\n",
            "ubiquitously include provisions to protect a woman’s life. E.g., Miss. Code Ann. § 41-\n",
            "41-45(2). They commonly include exceptions in other circumstances too. E.g., ibid.\n",
            "(abortion permitted “where the pregnancy was caused by rape”). Many States have\n",
            "passed laws that address the particular risks presented by chemical abortions. Such\n",
            "laws recognize, for example, that “abortion-inducing drugs” “present[ ] significant\n",
            "medical risks to women” such as “uterine hemorrhage, viral infections, pelvic\n",
            "12Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 19 of 26 PageID 3778\n",
            "inflammatory disease, severe bacterial infection and death,” id. § 41-41-103(a); “are\n",
            "associated with an increased risk of complications relative to surgical abortion” that\n",
            "heightens “with increasing gestational age,” id. § 41-41-103(b); and “are\n",
            "contraindicated in ectopic pregnancies,” id. § 41-41-107(2). Given those risks, States\n",
            "have used their regulatory authority to direct (for example) that only physicians may\n",
            "provide such drugs, that a physician may do so only after “physically examin[ing] the\n",
            "woman and document[ing] ... the gestational age and intrauterine location of the\n",
            "pregnancy,” and that abortion drugs “must be administered in the same room and in\n",
            "the physical presence of the physician,” ensuring that the pregnant woman is\n",
            "informed of risks and monitored for complications. Id. §§ 41-41-107(2), (3); see, e.g.,\n",
            "Ind. Code Ann. § 16-34-2-1 (requiring in-person exam and dispensing); La. Stat. Ann.\n",
            "§ 40:1061.11 (requiring in-person dispensing); Okla. Stat. Ann. tit. 63, § 1-729.1\n",
            "(requiring in-person dispensing); Tex. Health & Safety Code Ann. § 171.063(b-1)\n",
            "(prohibiting shipment of abortion-inducing drugs “by courier, delivery, or mail\n",
            "service”). Last, like all methods of elective abortion, elective chemical abortion is\n",
            "generally unlawful in numerous States. E.g., Miss. Code. Ann. § 41-41-45(2) (abortion\n",
            "unlawful except “where necessary for the preservation of the mother’s life or where\n",
            "the pregnancy was caused by rape”).\n",
            "In the actions at issue here, the FDA has sought to impose a federal mail-order\n",
            "abortion regime that disregards the protections for life, health, and safety adopted by\n",
            "numerous States’ elected representatives. But the authority to “regulat[e] or\n",
            "prohibit[ ] abortion” belongs to “the citizens of each State.” Dobbs, 142 S. Ct. at 2284.\n",
            "The FDA may determine only whether mifepristone is “safe and effective” for its\n",
            "13Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 20 of 26 PageID 3779\n",
            "intended use. 21 C.F.R. §§ 314.2, 314.500. The agency has no authority to make broad\n",
            "policy judgments balancing the people’s interests in “prenatal life at all stages of\n",
            "development,” “maternal health and safety,” and “the integrity of the medical\n",
            "profession.” Dobbs, 142 S. Ct. at 2284. Legislatures have that authority, and state\n",
            "legislatures have balanced these interests and others in laws that reflect the views of\n",
            "constituent citizens. Insofar as the federal legislature has weighed in at all in this\n",
            "area, it has been to condemn what the FDA has done. Congress has expressly declared\n",
            "that drugs “designed, adapted, or intended for producing abortion ... shall not be\n",
            "conveyed in the mails.” 18 U.S.C. § 1461.\n",
            "State laws on chemical abortion thus account for the public interests at issue—\n",
            "and they do so with the benefit of democratic legitimacy (and legal authority). The\n",
            "FDA’s actions can make no such claim. By obstructing the judgments of elected\n",
            "representatives, the agency has undermined the public interest. Given the absence of\n",
            "authority for the FDA to establish a mail-order abortion regime—and States’ retained\n",
            "authority to act, U.S. Const. amend. X—the public interest strongly weighs against\n",
            "the FDA’s effort to override duly enacted state laws.\n",
            "C. The FDA’s Actions Harm The Public Interest By Undermining\n",
            "States’ Ability To Protect Their Citizens And Forcing States To\n",
            "Divert Scarce Resources To Investigating And Prosecuting\n",
            "Violations Of Their Laws.\n",
            "Even if the FDA’s approval of mifepristone harmonized with the agency’s own\n",
            "regulations and federal criminal law, those actions would not simply displace state\n",
            "laws regulating abortion. The amici States are entitled to enforce their duly enacted\n",
            "14Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 21 of 26 PageID 3780\n",
            "laws regulating chemical abortion in the interests of life, health, and safety. Yet the\n",
            "FDA’s actions will undercut those efforts and thus harm the public interest.\n",
            "The Biden Administration claims that it has the power to broadly make\n",
            "abortion drugs accessible despite contrary determinations by States and despite\n",
            "regulations that States may have enacted to protect life, health, and safety in the use\n",
            "of those drugs. See Memorandum on Further Efforts to Protect Access to Reproductive\n",
            "Healthcare Services, The White House (Jan. 22, 2023), http://bit.ly/3kEZrPl (Biden\n",
            "Memorandum). That claim is wrong. No federal law manifests Congress’s “clear and\n",
            "manifest purpose” to displace state law in this context. Rice v. Santa Fe Elevator\n",
            "Corp., 331 U.S. 218, 230 (1947); see also ibid. (Courts should “start with the\n",
            "assumption that the historic police powers of the States [are] not to be superseded ...\n",
            "unless that was the clear and manifest purpose of Congress.”). The need for a clear\n",
            "statement from Congress “is heightened” where, as here, an “administrative\n",
            "interpretation alters the federal-state framework by permitting federal\n",
            "encroachment upon a traditional state power.” Solid Waste Agency of N. Cook Cnty.\n",
            "v. U.S. Army Corps of Engineers, 531 U.S. 159, 173 (2001); see also Metro. Life, 471\n",
            "U.S. at 740 (Courts “must presume that Congress did not intend to pre-empt areas of\n",
            "traditional state regulation.”). As discussed above, the relevant federal statutes\n",
            "criminalize sending or receiving abortion drugs by mail and thus affirmatively\n",
            "condemn the FDA’s actions. Supra Part B. States are thus entitled to enforce their\n",
            "laws—protecting life, health, and safety—against persons and businesses involved in\n",
            "distributing or receiving abortion drugs by mail.\n",
            "15Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 22 of 26 PageID 3781\n",
            "Yet the FDA’s actions will undermine States’ laws, undercut their efforts to\n",
            "enforce them, and—as a result—harm the public interest.\n",
            "First, the FDA’s actions will undermine States’ ability to protect their citizens.\n",
            "Those actions will lead to the widespread shipment and use of abortion-inducing\n",
            "drugs. See Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says,\n",
            "N.Y. Times (Jan. 3, 2023), http://bit.ly/3WFFxB0. That widespread use will often\n",
            "occur in defiance of state laws that protect life, health, and safety. See Retail\n",
            "Pharmacies Can Now Offer Abortion Pill, FDA Says, Politico (Jan. 3, 2023),\n",
            "http://bit.ly/3wCPl3V (“Telemedicine and mail delivery of the pills has allowed\n",
            "patients to circumvent state bans.”). Indeed, the whole point of the Administration’s\n",
            "recent actions is to encourage and achieve evasion of those state laws. Such evasion—\n",
            "particularly when coupled with the FDA’s abandonment of key protections on\n",
            "mifepristone’s use—will harm the citizens of the amici States. That harm defies the\n",
            "public interest.\n",
            "Second, the FDA’s actions will force States to devote scarce resources to\n",
            "investigating and prosecuting violations of their laws. As the FDA continues a\n",
            "campaign that will harm amici’s citizens, amici will not sit by. Amici will enforce their\n",
            "laws to protect their citizens. But the FDA’s actions will make that task hard. The\n",
            "FDA—and the broader Administration—is encouraging lawbreaking on a mass scale.\n",
            "The new regime will require States to divert scarce resources to investigate and\n",
            "prosecute violations of their laws to vindicate the public interests that those laws\n",
            "represent. Cf. Maine v. Taylor, 477 U.S. 131, 137 (1986) (“[A] State clearly has a\n",
            "legitimate interest in the continued enforceability of its own statutes.”); Texas v.\n",
            "16Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 23 of 26 PageID 3782\n",
            "United States, 787 F.3d 733, 749 (5th Cir. 2015) (“[S]tates have a sovereign interest\n",
            "in the power to create and enforce a legal code.”) (internal quotation marks omitted).\n",
            "Such enforcement will be especially hard in these circumstances, given the\n",
            "Administration’s position that it will not enforce existing federal restrictions on\n",
            "abortion drugs, will treat state laws as “barriers” to be avoided, and can be expected\n",
            "to stymie and defy States’ efforts to enforce their own laws. Biden Memorandum; cf.\n",
            "Remarks of President Joe Biden—State of the Union Address as Prepared for\n",
            "Delivery, The White House (Feb. 7, 2023), http://bit.ly/3RHeAfn (reaffirming\n",
            "opposition to States that are protecting life and health after Dobbs). All of this\n",
            "subverts the public interest and the equities represented by validly enacted state\n",
            "laws. It strongly supports injunctive relief.\n",
            "* * *\n",
            "The serious nature of the FDA’s unlawful actions, and the agency’s decision to\n",
            "invite lawbreaking by private parties and government actors across the country,\n",
            "favors broad relief. The FDA and the Administration as a whole have no intention to\n",
            "respect the Constitution, the Supreme Court, or the democratic process when it comes\n",
            "to abortion. This Court’s decisive action is warranted.\n",
            "17Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 24 of 26 PageID 3783\n",
            "CONCLUSION\n",
            "The public interest and equities support relief against the FDA’s actions.\n",
            "Dated: February 13, 2023\n",
            "Respectfully submitted,\n",
            "LYNN FITCH\n",
            "Attorney General\n",
            "/s/ Justin L. Matheny\n",
            "SCOTT G. STEWART (MS Bar No. 106359)\n",
            "Solicitor General\n",
            "JUSTIN L. MATHENY (MS Bar No.\n",
            "100754)\n",
            "Deputy Solicitor General\n",
            "MISSISSIPPI ATTORNEY\n",
            "GENERAL’S OFFICE\n",
            "P.O. Box 220\n",
            "Jackson, MS 39205-0220\n",
            "Telephone: (601) 359-3680\n",
            "Fax: (601) 359-2003\n",
            "justin.matheny@ago.ms.gov\n",
            "Counsel for Amici Curiae\n",
            "18Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 25 of 26 PageID 3784\n",
            "On behalf of:\n",
            "Steve Marshall Treg Taylor\n",
            "Attorney General Attorney General\n",
            "State of Alabama State of Alaska\n",
            "Tim Griffin Ashley Moody\n",
            "Attorney General Attorney General\n",
            "State of Arkansas State of Florida\n",
            "Christopher M. Carr Raúl R. Labrador\n",
            "Attorney General Attorney General\n",
            "State of Georgia State of Idaho\n",
            "Theodore E. Rokita Brenna Bird\n",
            "Attorney General Attorney General\n",
            "State of Indiana State of Iowa\n",
            "Kris W. Kobach Daniel Cameron\n",
            "Attorney General Attorney General\n",
            "State of Kansas Commonwealth of Kentucky\n",
            "Jeff Landry Austin Knudsen\n",
            "Attorney General Attorney General\n",
            "State of Louisiana State of Montana\n",
            "Michael T. Hilgers Dave Yost\n",
            "Attorney General Attorney General\n",
            "State of Nebraska State of Ohio\n",
            "Gentner F. Drummond Alan Wilson\n",
            "Attorney General Attorney General\n",
            "State of Oklahoma State of South Carolina\n",
            "Marty J. Jackley Jonathan Skrmetti\n",
            "Attorney General Attorney General\n",
            "State of South Dakota State of Tennessee\n",
            "Ken Paxton Sean D. Reyes\n",
            "Attorney General Attorney General\n",
            "State of Texas State of Utah\n",
            "Bridget Hill\n",
            "Attorney General\n",
            "State of Wyoming\n",
            "19Case 2:22-cv-00223-Z Document 100 Filed 02/13/23 Page 26 of 26 PageID 3785\n",
            "CERTIFICATE OF SERVICE\n",
            "I hereby certify that the foregoing brief has been served on all counsel of record\n",
            "by ECF.\n",
            "Dated: February 13, 2023\n",
            "/s/ Justin L. Matheny\n",
            "Justin L. Matheny\n",
            "Counsel for Amici Curiae\n",
            "20\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(preprocessed_text)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "rPpM1Ra1-Sx3",
        "outputId": "c7691faa-38e0-4388-90c2-c795fd65ef33"
      },
      "execution_count": 30,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 1 26 PageID 3760 \n",
            " UNITED STATES DISTRICT COURT \n",
            " NORTHERN DISTRICT of TEXAS \n",
            " AMARILLO DIVISION \n",
            " ALLIANCE for HIPPOCRATIC \n",
            " MEDICINE et al \n",
            " plaintiff \n",
            " v. Case no 2:22 cv-00223 Z \n",
            " U.S. FOOD and DRUG \n",
            " ADMINISTRATION et al \n",
            " defendant \n",
            " AMICUS CURIAE BRIEF of MISSISSIPPI ALABAMA ALASKA \n",
            " ARKANSAS FLORIDA GEORGIA IDAHO INDIANA IOWA KANSAS \n",
            " KENTUCKY LOUISIANA MONTANA NEBRASKA OHIO OKLAHOMA \n",
            " SOUTH CAROLINA south DAKOTA TENNESSEE TEXAS UTAH and \n",
            " WYOMING in SUPPORT of PLAINTIFFS ' MOTION \n",
            " for PRELIMINARY INJUNCTIONCase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 2 26 PageID 3761 \n",
            " table of content \n",
            " Page \n",
            " table of AUTHORITIES .......................................................................................... ii \n",
            " INTRODUCTION interest of AMICI CURIAE \n",
            " and SUMMARY of ARGUMENT .............................................................................. 1 \n",
            " BACKGROUND ............................................................................................................. 4 \n",
            " argument .................................................................................................................. 7 \n",
            " the Public Interest and Equities Support Injunctive Relief against the FDA ’s \n",
            " Actions on Mifepristone ........................................................................................ 7 \n",
            " a. the Public Interest and Equities weigh strongly against the FDA ’s action \n",
            " because those Actions Defy Federal Law ....................................................... 8 \n",
            " B. the FDA ’s Actions Undermine the Public Interest Determinations that \n",
            " state — not Federal Agencies — be entitle to make ................................ 11 \n",
            " C. the FDA ’s Actions Harm the Public Interest by Undermining States ' ability \n",
            " to protect their Citizens and force state to Divert Scarce Resources to \n",
            " investigate and prosecute violation of their Laws ............................ 14 \n",
            " CONCLUSION ............................................................................................................. 18 \n",
            " icase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 3 26 PageID 3762 \n",
            " table of AUTHORITIES \n",
            " Page(s \n",
            " case \n",
            " Dobbs v. Jackson Women ’s Health Organization \n",
            " 142 S. Ct 2228 2022 ............................................................ 1 2 11 12 13 14 17 \n",
            " Gonzales v. Oregon \n",
            " 546 U.S. 243 2006 ................................................................................................ 12 \n",
            " Hillsborough Cnty Fla. v. Automated Med Laboratories Inc. \n",
            " 471 U.S. 707 1985 ................................................................................................ 12 \n",
            " Maine v. Taylor \n",
            " 477 U.S. 131 1986 ................................................................................................ 16 \n",
            " Metro Life Ins Co. v. Massachusetts \n",
            " 471 U.S. 724 1985 .......................................................................................... 12 15 \n",
            " Rice v. Santa Fe Elevator Corp. \n",
            " 331 U.S. 218 1947 ................................................................................................ 15 \n",
            " Solid Waste Agency N. Cook Cnty v. U.S. Army Corps Engineers \n",
            " 531 U.S. 159 2001 ................................................................................................ 15 \n",
            " Texas v. Biden \n",
            " 10 f.4th 538 5th Cir 2021 ............................................................................... 8 11 \n",
            " Texas v. United States \n",
            " 787 F.3d 733 5th Cir 2015 ............................................................................. 16 17 \n",
            " Valley v. Rapides Parish Sch Bd \n",
            " 118 f.3d 1047 5th Cir 1997 ............................................................................ 8 11 \n",
            " Wages White Lion Invs LLC v. FDA \n",
            " 16 f.4th 1130 5th Cir 2021 ................................................................................... 8 \n",
            " Constitutional Provision \n",
            " U.S. Const amend x ................................................................................................... 14 \n",
            " iicase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 4 26 PageID 3763 \n",
            " statute \n",
            " 18 U.S.C. § 1461 ............................................................................................... 10 11 14 \n",
            " 18 U.S.C. § 1462 ..................................................................................................... 10 11 \n",
            " 21 U.S.C. § 321 ............................................................................................................... 4 \n",
            " 21 U.S.C. § 355 ............................................................................................................... 4 \n",
            " 21 U.S.C. § 355 1 ............................................................................................................ 5 \n",
            " 21 U.S.C. § 393 ............................................................................................................... 4 \n",
            " Food Drug Administration Amendments Act \n",
            " Pub L. No 110 85 121 Stat 823 2007 ............................................................. 5 9 \n",
            " Ind. Code Ann § 16 34 2 1 .......................................................................................... 13 \n",
            " La. Stat Ann § 40:1061.11 ......................................................................................... 13 \n",
            " Miss. Code Ann § 41 41 45 ................................................................................... 12 13 \n",
            " Miss. Code Ann § 41 41 103 ....................................................................................... 13 \n",
            " Miss. Code Ann § 41 41 107 ....................................................................................... 13 \n",
            " Okla. Stat Ann tit 63 § 1 729.1 ............................................................................... 13 \n",
            " Pub L. No 91 662 84 Stat 1973 1971 .................................................................... 10 \n",
            " Tex Health Safety Code Ann § 171.063 ................................................................ 13 \n",
            " Executive Order \n",
            " protect Access Reproductive Healthcare Services \n",
            " Exec Order No 14076 \n",
            " 87 Fed Reg 42053 2022 .................................................................................. 2 11 \n",
            " Regulations \n",
            " 21 C.F.R. § 314.2 ..................................................................................................... 13 14 \n",
            " 21 C.F.R. § 314.500 ............................................................................... 4 8 9 10 13 14 \n",
            " iiicase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 5 26 PageID 3764 \n",
            " 21 C.F.R. § 314.520 ........................................................................................................ 4 \n",
            " 21 C.F.R. § § 314.500 314.560 ........................................................................................ 5 \n",
            " rulemake \n",
            " New Drug Antibiotic Biological Drug Product Regulations \n",
            " Accelerated Approval \n",
            " 57 Fed Reg 58942 Dec. 11 1992 .......................................................................... 9 \n",
            " other authority \n",
            " Abortion pill can now be offer Retail Pharmacies F.D.A. say \n",
            " N.Y. Times Jan. 3 2023 ....................................................................................... 16 \n",
            " Fact Sheet President Biden announce Actions in Light \n",
            " today ’s Supreme Court Decision Dobbs v. Jackson \n",
            " Women ’s Health Organization \n",
            " the White House June 24 2022 ............................................................................ 2 \n",
            " Fact Sheet President Biden sign Presidential Memorandum \n",
            " Ensuring Safe Access Medication Abortion \n",
            " the White House Jan. 22 2023 ............................................................................. 2 \n",
            " H.R. 13959 95th Cong 1978 .................................................................................... 10 \n",
            " H.R. Rep. No 29 1979 ............................................................................................... 10 \n",
            " Memorandum further Efforts protect Access \n",
            " Reproductive Healthcare Services \n",
            " the White House Jan. 22 2023 ................................................................. 2 15 17 \n",
            " NIH Nat’l Library Medicine ..................................................................................... 4 \n",
            " Remarks President Joe Biden — State Union Address \n",
            " Prepared Delivery \n",
            " the White House Feb. 7 2023 ............................................................................. 17 \n",
            " Retail Pharmacies can now offer Abortion Pill FDA say \n",
            " Politico Jan. 3 2023 ............................................................................................. 16 \n",
            " U.S. Food Drug Admin \n",
            " information Mifepristone Medical Termination \n",
            " Pregnancy through ten week Gestation ........................................................... 6 7 \n",
            " ivcase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 6 26 PageID 3765 \n",
            " U.S. Food Drug Admin \n",
            " Risk Evaluation Mitigation Strategies ............................................................. 5 \n",
            " vCase 2:22 cv-00223 Z Document 100 file 02/13/23 Page 7 26 PageID 3766 \n",
            " INTRODUCTION interest of AMICI CURIAE \n",
            " and SUMMARY of ARGUMENT \n",
            " last year Supreme Court hold abortion matter entrust \n",
            " \" people elect representative \" address Dobbs v. Jackson \n",
            " Women ’s Health Organization 142 S. Ct 2228 2284 2022 overrule precedent \n",
            " take authority away people Court return issue \n",
            " \" regulate prohibit abortion \" \" citizen State \" ibid States may \n",
            " thus pursue \" legitimate interest \" protect unborn life woman ’s health \n",
            " medical profession ’s integrity regulate restrict abortion ibid \n",
            " amici curiae States Mississippi Alabama Alaska Arkansas \n",
            " Florida Georgia Idaho Indiana Iowa Kansas Kentucky Louisiana Montana \n",
            " Nebraska Ohio Oklahoma South Carolina South Dakota Tennessee Texas Utah \n",
            " Wyoming like States amici consistent Constitution \n",
            " Supreme Court ’s decision Dobbs adopt law regulate abortion — include \n",
            " chemical abortion those law strike balance among compete interest \n",
            " result hard fight democratic process embody consider \n",
            " judgment \" people elect representative \" ibid some state \n",
            " choose adopt maintain tight restriction thorough regulation \n",
            " abortion Dobbs other States continue embrace permissive \n",
            " regime all state provision abortion law protect woman ’s life \n",
            " commonly include exception circumstance these choice reflect \n",
            " approach Constitution envision address complex issue require \n",
            " \" legislative body \" \" draw line accommodate compete interest \" id. 2268 \n",
            " 1case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 8 26 PageID 3767 \n",
            " rather respect Constitution Supreme Court democratic \n",
            " process Biden Administration attack work undermine \n",
            " consider judgment elect representative States like amici the \n",
            " Administration ’s action abortion drug typify effort the day Dobbs \n",
            " decide President Biden direct Administration ensure abortion drug \n",
            " \" widely accessible possible \" include \" telehealth send \n",
            " mail \" Fact Sheet President Biden announce Actions in Light today ’s Supreme \n",
            " Court Decision Dobbs v. Jackson Women ’s Health Organization the White House \n",
            " June 24 2022 http://bit.ly/3DqTmwd the President soon sign executive order \n",
            " lament States ’ regulation abortion direct federal agency \" expand \n",
            " access abortion care include medication abortion \" protect Access \n",
            " Reproductive Healthcare Services Exec Order No 14076 87 Fed Reg 42053 42053 \n",
            " 2022 just week ago President Biden sign memorandum spotlight \n",
            " Administration ’s effort \" evaluat[e monitor \" state law \" threaten \n",
            " infringe \" purport \" federal legal protection abortion \" Memorandum \n",
            " Further Efforts protect Access Reproductive Healthcare Services the White \n",
            " House Jan. 22 2023 http://bit.ly/3kEZrPl he also express intent promote \n",
            " access abortion drug patient provider \" matter live \" Fact \n",
            " Sheet President Biden Sign Presidential Memorandum Ensuring Safe Access \n",
            " Medication Abortion the White House Jan. 22 2023 http://bit.ly/3I160Vn \n",
            " although Biden Administration follow Dobbs double \n",
            " effort impose country elective abortion policy could never achieve \n",
            " democratic process goal new — especially abortion drug \n",
            " 2case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 9 26 PageID 3768 \n",
            " for two decade U.S. Food Drug Administration act establish \n",
            " nationwide regime demand abortion license sweeping access chemical \n",
            " abortion drug — defiance federal state law protect life health \n",
            " safety see Pls ' mot 2 6 Dkt 7 in 2000 FDA purport approve drug \n",
            " mifepristone chemically induce abortion 49 day pregnancy that \n",
            " approval basic legal problem include safety measure \n",
            " account mifepristone ’s serious risk life health yet time FDA \n",
            " cast even measure aside in 2016 FDA roll back many safety \n",
            " requirement — allow mifepristone prescribe later pregnancy non- \n",
            " doctor one person visit in 2021 agency halt remain \n",
            " person dispense requirement covid-19 pandemic later \n",
            " abandon requirement altogether after decade effort FDA \n",
            " broadly condone wide range mail order abortion drug regime plaintiff \n",
            " move preliminarily enjoin set aside FDA ’s action \n",
            " this brief explain public interest equity strongly support relief \n",
            " FDA ’s action first FDA ’s action contravene federal law \n",
            " disserve public interest second FDA ’s action defy public interest \n",
            " determination make amici States entrust balance \n",
            " policy equitable consideration area last FDA ’s action threaten \n",
            " undermine amici States ’ enforcement duly enact law thus undercut \n",
            " public interest law promote for reason injunctive relief \n",
            " FDA ’s action would promote public interest \n",
            " 3case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 10 26 PageID 3769 \n",
            " BACKGROUND \n",
            " the Federal Food Drug Cosmetic Act direct U.S. Food Drug \n",
            " Administration \" protect public health ensure ... human \n",
            " veterinary drug safe effective \" 21 U.S.C. § 393(b)(2)(b under Act \n",
            " FDA responsible approve \" new drug \" market distribute \n",
            " public id. § 321(p)(1 the Act bar anyone \" introduc[e deliver[ing \n",
            " introduction interstate commerce new drug \" without FDA \" approval \" Id. \n",
            " § 355(a to obtain FDA approval new drug must undergo extensive process \n",
            " rigorous testing the FDA ’s conclusion drug safe effective must \n",
            " base \" substantial evidence \" expert consensus id. § 355(d \n",
            " in 2000 FDA approve marketing distribution mifepristone \n",
            " \" medical termination intrauterine pregnancy 49 day ' pregnancy \" \n",
            " App.518 Dkt 8 Mifepristone synthetic steroid cause \" menstrual bleeding \n",
            " disruption endometrium uterine lining termination \" \n",
            " pregnancy Mifepristone NIH Nat’l Library Medicine http://bit.ly/403EjSN \n",
            " Mifepristone generally follow dose misoprostol cause pregnant \n",
            " woman ’s uterus contract expel detach embryo Id. Misoprostol \n",
            " http://bit.ly/3DgTpKZ \n",
            " the FDA approve mifepristone Subpart H agency ’s regulation \n",
            " implement agency ’s general authority approve new drug \" \n",
            " study safety effectiveness treat serious life threaten \n",
            " illness \" 21 C.F.R. § 314.500 \" safely use distribution use \n",
            " restrict \" d. § 314.520 to satisfy Subpart H FDA need — — deem \n",
            " 4case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 11 26 PageID 3770 \n",
            " pregnancy \" serious life threaten illness \" even absence \n",
            " complication conclude mifepristone \" safe \" \" provide[d \n",
            " meaningful therapeutic benefit \" App.523 cite 21 C.F.R. § § 314.500 314.560 \n",
            " despite approve mifepristone FDA recognize serious risk \" urgent \n",
            " adverse event[ associate \" drug — include incomplete abortion severe \n",
            " bleeding require surgery App.522 these risk increase later pregnancy \n",
            " case ectopic pregnancy App.518 25 607 09 the approval thus include \n",
            " requirement drug provide \" supervision \n",
            " physician \" ability \" assess duration pregnancy accurately \" \" diagnose \n",
            " ectopic pregnancy \" \" provide arrange surgical intervention case \n",
            " incomplete abortion severe bleeding \" \" assure patient access medical \n",
            " facility equip provide blood transfusion resuscitation \" App.523 \n",
            " in 2007 Congress enact Food Drug Administration Amendments \n",
            " Act Pub L. No 110 85 121 Stat 823 2007 that law affect FDA approval \n",
            " Subpart H. it direct agency adopt Risk Evaluation Mitigation Strategy \n",
            " rems new drug \" necessary ensure benefit drug \n",
            " outweigh risk \" 21 U.S.C. § 355 1(a)(1)-(2 a rems operate \" drug safety \n",
            " program \" medication present \" serious safety concern \" U.S. Food Drug \n",
            " Admin Risk Evaluation Mitigation Strategies http://bit.ly/3wKOwGp see ibid \n",
            " \" while medication label inform health care stakeholder \n",
            " medication risk medication require rems \" because serious \n",
            " safety concern involve FDA establish rems program mifepristone \n",
            " 2011 various \" element assure safe use \" include requirement \n",
            " 5case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 12 26 PageID 3771 \n",
            " drug dispense certain healthcare setting — clinic medical office \n",
            " hospital — supervision certify prescriber app.731 32 \n",
            " despite risk FDA recognize next decade \n",
            " beyond Obama Biden Administrations expand mifepristone ’s use \n",
            " drop safety measure erect around in 2016 FDA extend \n",
            " approve use mifepristone 70 day 10 week pregnancy allow \n",
            " broad set person prescribe drug reduce number require in- \n",
            " person patient visit three one app.625 52 732 but agency maintain \n",
            " requirement least one person visit drug could dispense \n",
            " clinic medical office hospital supervision certify \n",
            " healthcare provider app.733 \n",
            " in April 2021 however FDA stop enforce person dispense \n",
            " requirement the FDA attribute decision \" covid relate risk \" in- \n",
            " person dispense app.715 the agency add would \" exercise enforcement \n",
            " discretion covid-19 public health emergency respect \n",
            " dispensing mifepristone mail \" ibid \n",
            " in December 2021 FDA abandon person dispense requirement \n",
            " altogether app.735 it make decision independent covid relate risk \n",
            " despite recognize \" certain element Mifepristone rems Program \" — \n",
            " include \" healthcare provider certification dispensing mifepristone \n",
            " patient evidence documentation safe use conditions”—“remain \n",
            " necessary assure safe use mifepristone \" \" ensure benefit \n",
            " mifepristone outweigh risk \" ibid on January 3 2023 FDA modify \n",
            " 6case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 13 26 PageID 3772 \n",
            " mifepristone rems program make clear agency ’s position drug \n",
            " dispense certify prescriber retail pharmacy \" person mail \" \n",
            " U.S. Food Drug Admin information Mifepristone Medical Termination \n",
            " Pregnancy through ten Weeks Gestation http://bit.ly/3kHmh8Q. \n",
            " while FDA authorize evaluate new drug safety effectiveness \n",
            " state primarily responsible protect health welfare \n",
            " citizen many state include several amici thus enact law \n",
            " regulate abortion induce drug account danger such law \n",
            " include person examination dispensing requirement qualification \n",
            " requirement prescriber mandate informed consent ban distribution \n",
            " mailing combination safety limitation see infra \n",
            " the lawsuit seek enjoin panoply agency action \n",
            " FDA approve mifepristone make widely accessible discard \n",
            " measure manage risk present \n",
            " ARGUMENT \n",
            " the Public Interest and Equities Support Injunctive Relief against \n",
            " the FDA ’s Actions on Mifepristone \n",
            " the FDA ’s challenge action mifepristone deeply flawed they defy \n",
            " federal law flout public interest determination state properly make \n",
            " undermine public interest enforcement validly enact state law \n",
            " these feature strongly support injunctive relief agency ’s action \n",
            " 7case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 14 26 PageID 3773 \n",
            " a. the Public Interest and Equities weigh strongly against the \n",
            " FDA ’s action because those Actions Defy Federal Law \n",
            " plaintiff demonstrate FDA ’s action mifepristone violate \n",
            " Federal Food Drug Cosmetic Act relate FDA regulation see Pls ' Mot \n",
            " 14 23 Amici emphasize FDA ’s action defy agency ’s regulation \n",
            " also federal law restrict mailing abortion drug the public interest \n",
            " equity thus favor injunctive relief FDA ’s action \n",
            " an agency action defy public interest unlawful \" there generally \n",
            " public interest perpetuation unlawful agency action \" Texas v. Biden \n",
            " 10 F.4th 538 560 5th Cir 2021 bracket omit see also Wages White Lion \n",
            " Invs LLC v. FDA 16 f.4th 1130 1143 5th Cir 2021 allow illegal action \n",
            " government agency stand \" undermine[s \" public interest Valley v. Rapides \n",
            " Parish Sch Bd 118 F.3d 1047 1056 5th Cir 1997 and strong public \n",
            " interest \" governmental agency abide federal law govern \n",
            " existence operation \" Biden 10 f.4th 559 \n",
            " the FDA ’s action two basic legal flaw \n",
            " first FDA ’s approval mifepristone defy agency ’s regulation \n",
            " as note agency rely Subpart H regulation first approve \n",
            " mifepristone 2000 Subpart H permit FDA approve \" certain new drug \n",
            " product study safety effectiveness treat serious \n",
            " life threaten illness provide meaningful therapeutic benefit \n",
            " patient exist treatment \" 21 C.F.R. § 314.500 emphasis add that \n",
            " regulation doubly foreclose FDA ’s approval pregnancy \" illness \" it \n",
            " natural state essential perpetuate human life and typical early stage \n",
            " 8case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 15 26 PageID 3774 \n",
            " pregnancy without complication condition \" serious life- \n",
            " threaten \" require \" treatment \" mifepristone provide \n",
            " the FDA admit pregnancy illness claim \n",
            " rulemaking \" explain Subpart H available serious life threaten \n",
            " ' condition ' whether understand colloquially ' illness ' \" Opp \n",
            " 26 Dkt 28 quote New Drug Antibiotic Biological Drug Product Regulations \n",
            " Accelerated Approval 57 Fed Reg 58942 58946 Dec. 11 1992 but \n",
            " unambiguous regulation — agency ’s aspirational gloss — control as \n",
            " explain clear regulatory text defeat FDA ’s view thus approval \n",
            " mifepristone at FDA ’s argument suggest could approve \n",
            " mifepristone Subpart H case pregnant woman ’s life health \n",
            " seriously danger that — FDA still would \n",
            " stick reality pregnancy \" illness \" 21 C.F.R. § 314.500 \n",
            " Subpart H permit agency greenlight elective abortion wide scale \n",
            " the FDA also claim \" hypothetical error initial reliance \n",
            " Subpart H \" \" overtake congressional action \" Opp 25 26 this \n",
            " argument agency confident legality action and \n",
            " argument fail when Congress establish rems framework 2007 \n",
            " temporarily \" deem effect approve risk evaluation mitigation \n",
            " strategy \" \" drug previously approve \" Subpart H \" element \n",
            " assure safe use \" Pub L. No 110 85 § 909(b)(1 121 Stat 950 require \n",
            " sponsor drug \" submit FDA propose risk evaluation \n",
            " mitigation strategy \" within 180 day d. § 909(b)(3 121 Stat 951 this mean \n",
            " 9case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 16 26 PageID 3775 \n",
            " Congress \" deem \" preexist safety requirement sufficient rems \n",
            " program new 2007 law new strategy approve that law \n",
            " affect whether drug properly authorize Subpart H first place \n",
            " treat \" serious life threaten illness \" 21 C.F.R. § 314.500 congressional \n",
            " action blot FDA ’s defiance regulation \n",
            " Second FDA ’s action defy federal criminal law longstanding federal law \n",
            " provide \" e]very article thing design adapt intend produce \n",
            " abortion ... i]s declare nonmailable matter shall convey \n",
            " mail deliver post office letter carrier \" 18 U.S.C. § 1461 a \n",
            " relate statute make federal crime \" knowingly use express company \n",
            " common carrier \" ship \" interstate foreign commerce ... drug \n",
            " medicine article thing design adapt intend produce abortion \" Id. \n",
            " § 1462 violation either statute punishable five year \n",
            " imprisonment Id. § § 1461 1462 these statute prohibit use mail send \n",
            " receive abortion induce drug mifepristone the statute ’ restriction \n",
            " abortion remain place — even Congress repeal part \n",
            " law see Pub L. No 91 662 84 Stat 1973 1971 repeal certain restriction \n",
            " contraceptive section 1461 Congress also consider \n",
            " narrow statute target intent requirement see H.R. 13959 95th \n",
            " Cong § § 6701(a)(1)(2 6702(1)(c)(i 1978 see also H.R. Rep. No 29 pt 3 42 \n",
            " 1979 explain bill would \" change[d current law \" those effort fail \n",
            " a late break memo Biden Justice Department see application \n",
            " Comstock Act Mailing Prescription drug that can be use abortion \n",
            " 10case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 17 26 PageID 3776 \n",
            " 46 Op OLC Dec. 23 2022 read section 1461 1462 intent \n",
            " requirement Congress refuse enact but memo paper clear \n",
            " statutory language historical reality Congress alter relevant \n",
            " text \n",
            " the FDA ’s challenge action mifepristone thus defy agency ’s \n",
            " regulatory authority longstanding federal criminal law because action \n",
            " war law FDA claim public interest enforce \n",
            " indeed enjoin FDA \" abide \" federal law would promote public \n",
            " interest Biden 10 f.4th 559 — issue injunctive relief would \" undermine \" \n",
            " public interest Valley 118 f.3d 1056 \n",
            " B. the FDA ’s Actions Undermine the Public Interest \n",
            " Determinations that state — not Federal Agencies — be \n",
            " entitle to make \n",
            " the FDA respond change circumstance safety \n",
            " mifepristone cast aside longstanding requirement person \n",
            " dispensing nor agency follow legislative mandate Congress \n",
            " promote new mail order abortion regime rather agency act \n",
            " behest Biden Administration ally demand political action \n",
            " Dobbs after decision Administration swiftly declare duly enact \n",
            " state law abortion \" devastating implication \" \" public health \" \n",
            " federal government would act \" expand access abortion care include \n",
            " medication abortion \" protect Access Reproductive Healthcare Services Exec \n",
            " Order No 14076 87 Fed Reg 42053 42053 2022)—despite consider judgment \n",
            " elect representative address health interest stake but \n",
            " 11case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 18 26 PageID 3777 \n",
            " Supreme Court recognize responsibility elect representative \n",
            " state — unelecte bureaucrat federal agency — strike balance \n",
            " \" compete interest \" abortion dobb 142 S. Ct 2268 the FDA ’s action seek \n",
            " override balance properly strike States if allow stand action \n",
            " harm public interest \n",
            " under Constitution States primary authority legislate \n",
            " protect health safety welfare citizen Hillsborough Cnty Fla. v. \n",
            " Automated Med Laboratories Inc. 471 U.S. 707 719 1985 \" t]he regulation \n",
            " health safety matter primarily historically matter local concern \" \n",
            " Metro Life Ins Co. v. Massachusetts 471 U.S. 724 756 1985 \" the state \n",
            " traditionally great latitude police power legislate \n",
            " protection life limb health comfort quiet person \" internal \n",
            " quotation mark omit this power include regulate medical profession \n",
            " set standard care Gonzales v. Oregon 546 U.S. 243 270 2006 \" a \n",
            " function medical profession regulate States ’ police power \" \n",
            " use authority States adopt vary approach abortion \n",
            " reflect policy decision constituent citizen state law restrict abortion \n",
            " ubiquitously include provision protect woman ’s life E.g. Miss. Code Ann § 41- \n",
            " 41 45(2 they commonly include exception circumstance E.g. ibid \n",
            " abortion permit \" pregnancy cause rape \" many state \n",
            " pass law address particular risk present chemical abortion such \n",
            " law recognize example \" abortion induce drug \" \" present significant \n",
            " medical risk woman \" \" uterine hemorrhage viral infection pelvic \n",
            " 12case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 19 26 PageID 3778 \n",
            " inflammatory disease severe bacterial infection death \" d. § 41 41 103(a \" \n",
            " associate increase risk complication relative surgical abortion \" \n",
            " heighten \" increase gestational age \" d. § 41 41 103(b \" \n",
            " contraindicate ectopic pregnancy \" d. § 41 41 107(2 give risk States \n",
            " use regulatory authority direct example physician may \n",
            " provide drug physician may \" physically examin[e \n",
            " woman document[ing ... gestational age intrauterine location \n",
            " pregnancy \" abortion drug \" must administer room \n",
            " physical presence physician \" ensure pregnant woman \n",
            " inform risk monitor complication Id. § § 41 41 107(2 3 see e.g. \n",
            " Ind. Code Ann § 16 34 2 1 require person exam dispensing La. Stat Ann \n",
            " § 40:1061.11 require person dispense Okla. Stat Ann tit 63 § 1 729.1 \n",
            " require person dispense Tex Health Safety Code Ann § 171.063(b-1 \n",
            " prohibit shipment abortion induce drug \" courier delivery mail \n",
            " service \" last like method elective abortion elective chemical abortion \n",
            " generally unlawful numerous States E.g. Miss. Code Ann § 41 41 45(2 abortion \n",
            " unlawful except \" necessary preservation mother ’s life \n",
            " pregnancy cause rape \" \n",
            " in action issue FDA seek impose federal mail order \n",
            " abortion regime disregard protection life health safety adopt \n",
            " numerous States ' elect representative but authority \" regulat[e \n",
            " prohibit abortion \" belong \" citizen State \" Dobbs 142 S. Ct 2284 \n",
            " the FDA may determine whether mifepristone \" safe effective \" \n",
            " 13case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 20 26 PageID 3779 \n",
            " intend use 21 C.F.R. § § 314.2 314.500 the agency authority make broad \n",
            " policy judgment balance people ’s interest \" prenatal life stage \n",
            " development \" \" maternal health safety \" \" integrity medical \n",
            " profession \" dobb 142 S. Ct 2284 legislature authority state \n",
            " legislature balance interest other law reflect view \n",
            " constituent citizen insofar federal legislature weigh \n",
            " area condemn FDA do Congress expressly declare \n",
            " drug \" design adapt intend produce abortion ... shall \n",
            " convey mail \" 18 U.S.C. § 1461 \n",
            " state law chemical abortion thus account public interest issue — \n",
            " benefit democratic legitimacy legal authority the \n",
            " FDA ’s action make claim by obstruct judgment elect \n",
            " representative agency undermine public interest give absence \n",
            " authority FDA establish mail order abortion regime — States ' retain \n",
            " authority act U.S. Const amend X — public interest strongly weigh \n",
            " FDA ’s effort override duly enact state law \n",
            " C. the FDA ’s Actions Harm the Public Interest by Undermining \n",
            " state ' ability to protect their Citizens and force state to \n",
            " Divert Scarce Resources to investigate and prosecute \n",
            " violation of their Laws \n",
            " even FDA ’s approval mifepristone harmonize agency ’s \n",
            " regulation federal criminal law action would simply displace state \n",
            " law regulate abortion the amici States entitle enforce duly enact \n",
            " 14case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 21 26 PageID 3780 \n",
            " law regulate chemical abortion interest life health safety yet \n",
            " FDA ’s action undercut effort thus harm public interest \n",
            " the Biden Administration claim power broadly make \n",
            " abortion drug accessible despite contrary determination States despite \n",
            " regulation States may enact protect life health safety use \n",
            " drug see Memorandum further Efforts protect Access Reproductive \n",
            " Healthcare Services the White House Jan. 22 2023 http://bit.ly/3kEZrPl Biden \n",
            " Memorandum that claim wrong no federal law manifest Congress ’s \" clear \n",
            " manifest purpose \" displace state law context Rice v. Santa Fe Elevator \n",
            " Corp. 331 U.S. 218 230 1947 see also ibid court \" start \n",
            " assumption historic police power States supersede ... \n",
            " unless clear manifest purpose Congress \" the need clear \n",
            " statement Congress \" heighten \" \" administrative \n",
            " interpretation alter federal state framework permit federal \n",
            " encroachment upon traditional state power \" Solid Waste Agency N. Cook Cnty \n",
            " v. U.S. Army Corps Engineers 531 U.S. 159 173 2001 see also Metro Life 471 \n",
            " U.S. 740 court \" must presume Congress intend pre empt area \n",
            " traditional state regulation \" as discuss relevant federal statute \n",
            " criminalize send receive abortion drug mail thus affirmatively \n",
            " condemn FDA ’s action Supra Part B. States thus entitle enforce \n",
            " law — protect life health safety — person business involve \n",
            " distribute receive abortion drug mail \n",
            " 15case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 22 26 PageID 3781 \n",
            " yet FDA ’s action undermine state ’ law undercut effort \n",
            " enforce — result — harm public interest \n",
            " first FDA ’s action undermine state ’ ability protect citizen \n",
            " those action lead widespread shipment use abortion induce \n",
            " drug see Abortion pill can now be offer Retail Pharmacies F.D.A. say \n",
            " N.Y. Times Jan. 3 2023 http://bit.ly/3WFFxB0 that widespread use often \n",
            " occur defiance state law protect life health safety see Retail \n",
            " Pharmacies can now offer Abortion Pill FDA say Politico Jan. 3 2023 \n",
            " http://bit.ly/3wcpl3v \" Telemedicine mail delivery pill allow \n",
            " patient circumvent state ban \" indeed whole point Administration ’s \n",
            " recent action encourage achieve evasion state law such evasion — \n",
            " particularly couple FDA ’s abandonment key protection \n",
            " mifepristone ’s use — harm citizen amici States that harm defy \n",
            " public interest \n",
            " Second FDA ’s action force States devote scarce resource \n",
            " investigate prosecute violation law as FDA continue \n",
            " campaign harm amici ’s citizen amici sit Amici enforce \n",
            " law protect citizen but FDA ’s action make task hard the \n",
            " FDA — broad Administration — encourage lawbreaking mass scale \n",
            " the new regime require States divert scarce resource investigate \n",
            " prosecute violation law vindicate public interest law \n",
            " represent Cf Maine v. Taylor 477 U.S. 131 137 1986 \" a State clearly \n",
            " legitimate interest continue enforceability statute \" Texas v. \n",
            " 16case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 23 26 PageID 3782 \n",
            " United States 787 F.3d 733 749 5th Cir 2015 \" s]tate sovereign interest \n",
            " power create enforce legal code \" internal quotation mark omit \n",
            " such enforcement especially hard circumstance give \n",
            " Administration ’s position enforce exist federal restriction \n",
            " abortion drug treat state law \" barrier \" avoid expect \n",
            " stymie defy States ’ effort enforce law Biden Memorandum cf \n",
            " Remarks President Joe Biden — State Union Address Prepared \n",
            " Delivery the White House Feb. 7 2023 http://bit.ly/3rheafn reaffirm \n",
            " opposition States protect life health Dobbs all \n",
            " subvert public interest equity represent validly enact state \n",
            " law it strongly support injunctive relief \n",
            " \n",
            " the serious nature FDA ’s unlawful action agency ’s decision \n",
            " invite lawbreaking private party government actor across country \n",
            " favor broad relief the FDA Administration whole intention \n",
            " respect Constitution Supreme Court democratic process come \n",
            " abortion this Court ’s decisive action warrant \n",
            " 17case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 24 26 PageID 3783 \n",
            " CONCLUSION \n",
            " the public interest equity support relief FDA ’s action \n",
            " date February 13 2023 \n",
            " Respectfully submit \n",
            " LYNN FITCH \n",
            " Attorney General \n",
            " /s/ Justin L. Matheny \n",
            " SCOTT G. STEWART MS Bar No 106359 \n",
            " Solicitor General \n",
            " JUSTIN L. MATHENY MS Bar No \n",
            " 100754 \n",
            " Deputy Solicitor General \n",
            " MISSISSIPPI ATTORNEY \n",
            " GENERAL ’S OFFICE \n",
            " P.O. Box 220 \n",
            " Jackson MS 39205 0220 \n",
            " Telephone 601 359 3680 \n",
            " Fax 601 359 2003 \n",
            " justin.matheny@ago.ms.gov \n",
            " Counsel Amici Curiae \n",
            " 18case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 25 26 PageID 3784 \n",
            " on behalf \n",
            " Steve Marshall Treg Taylor \n",
            " Attorney General Attorney General \n",
            " State Alabama State Alaska \n",
            " Tim Griffin Ashley Moody \n",
            " Attorney General Attorney General \n",
            " State Arkansas State Florida \n",
            " Christopher M. Carr Raúl R. Labrador \n",
            " Attorney General Attorney General \n",
            " State Georgia State Idaho \n",
            " Theodore E. Rokita Brenna Bird \n",
            " Attorney General Attorney General \n",
            " State Indiana State Iowa \n",
            " Kris W. Kobach Daniel Cameron \n",
            " Attorney General Attorney General \n",
            " State Kansas Commonwealth Kentucky \n",
            " Jeff Landry Austin Knudsen \n",
            " Attorney General Attorney General \n",
            " State Louisiana State Montana \n",
            " Michael T. Hilgers Dave Yost \n",
            " Attorney General Attorney General \n",
            " State Nebraska State Ohio \n",
            " Gentner F. Drummond Alan Wilson \n",
            " Attorney General Attorney General \n",
            " State Oklahoma State South Carolina \n",
            " Marty J. Jackley Jonathan Skrmetti \n",
            " Attorney General Attorney General \n",
            " State South Dakota State Tennessee \n",
            " Ken Paxton Sean D. Reyes \n",
            " Attorney General Attorney General \n",
            " State Texas State Utah \n",
            " Bridget Hill \n",
            " Attorney General \n",
            " State Wyoming \n",
            " 19case 2:22 cv-00223 Z Document 100 file 02/13/23 Page 26 26 PageID 3785 \n",
            " certificate of service \n",
            " I hereby certify forego brief serve counsel record \n",
            " ECF \n",
            " date February 13 2023 \n",
            " /s/ Justin L. Matheny \n",
            " Justin L. Matheny \n",
            " Counsel Amici Curiae \n",
            " 20\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(inputs)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "kIFFmMSN-V1v",
        "outputId": "4ae26ac0-5d66-49f1-8c8a-cafb4fa843c1"
      },
      "execution_count": 31,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'input_ids': tensor([[  101,  2553,  1016,  1024,  2570, 26226,  1011,  4002, 19317,  2509,\n",
            "          1062,  6254,  2531,  5371,  6185,  1013,  2410,  1013,  2603,  3931,\n",
            "          1015,  2656,  3931,  3593,  4261, 16086,  2142,  2163,  2212,  2457,\n",
            "          2642,  2212,  1997,  3146, 23204, 10486,  2407,  4707,  2005,  5099,\n",
            "          6873, 17510,  4200,  3802,  2632, 20579,  1058,  1012,  2553,  2053,\n",
            "          1016,  1024,  2570, 26226,  1011,  4002, 19317,  2509,  1062,  1057,\n",
            "          1012,  1055,  1012,  2833,  1998,  4319,  3447,  3802,  2632, 13474,\n",
            "         26445,  7874, 12731,  4360,  2063,  4766,  1997,  5900,  6041,  7397,\n",
            "          6751,  3516,  4108,  9795,  5242,  5947,  5111,  5612,  5773,  8124,\n",
            "          8506,  4058,  5858,  2148,  3792,  2148,  7734,  5298,  3146,  6646,\n",
            "          1998, 10622,  1999,  2490,  1997, 23953,  1005,  4367,  2005,  8824,\n",
            "         22928, 18382,  1016,  1024,  2570, 26226,  1011,  4002, 19317,  2509,\n",
            "          1062,  6254,  2531,  5371,  6185,  1013,  2410,  1013,  2603,  3931,\n",
            "          1016,  2656,  3931,  3593,  4261,  2575,  2487,  2795,  1997,  4180,\n",
            "          3931,  2795,  1997,  4614,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  2462,  4955,  3037,  1997, 26445,  6895,\n",
            "         12731,  4360,  2063,  1998, 12654,  1997,  6685,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1015,  4281,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1018,  6685,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,  1012,\n",
            "          1012,   102]]), 'token_type_ids': tensor([[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
            "         0, 0, 0, 0, 0, 0, 0, 0]]), 'attention_mask': tensor([[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
            "         1, 1, 1, 1, 1, 1, 1, 1]])}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "    logits = outputs.logits\n",
        "    print(logits)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "kgMMgO76-Zov",
        "outputId": "5a549bb8-7d3c-4609-e138-b3f89d74091d"
      },
      "execution_count": 32,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "tensor([[-0.1392,  0.4932]])\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "num_predictions = logits.size(1)\n",
        "top_k = min(10, num_predictions)\n",
        "predicted_class = torch.topk(logits, top_k).indices.tolist()\n",
        "print(predicted_class)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_-Bw572--d8X",
        "outputId": "07f8e2b2-13d5-4d46-cf19-381a5a57db2e"
      },
      "execution_count": 33,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[[1, 0]]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "from IPython.display import display\n",
        "\n",
        "# Assuming `key_items` is the list of key items obtained from your model\n",
        "key_items = [\n",
        "    \"Key Item 1: Argument summary 1\",\n",
        "    \"Key Item 2: Argument summary 2\",\n",
        "    \"Key Item 3: Argument summary 3\",\n",
        "    # Add more key items as needed\n",
        "]\n",
        "\n",
        "# Create a DataFrame to display the key items\n",
        "df = pd.DataFrame(key_items, columns=[\"Key Items\"])\n",
        "display(df)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 350
        },
        "id": "nEZaExhfG-H4",
        "outputId": "825be45b-72eb-45ec-c5f9-6e73e172915e"
      },
      "execution_count": 34,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "                        Key Items\n",
              "0  Key Item 1: Argument summary 1\n",
              "1  Key Item 2: Argument summary 2\n",
              "2  Key Item 3: Argument summary 3"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-80513506-f1d3-440e-b5fe-1eb8ed03ff5d\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Key Items</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Key Item 1: Argument summary 1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Key Item 2: Argument summary 2</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Key Item 3: Argument summary 3</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-80513506-f1d3-440e-b5fe-1eb8ed03ff5d')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-80513506-f1d3-440e-b5fe-1eb8ed03ff5d button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-80513506-f1d3-440e-b5fe-1eb8ed03ff5d');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-b1d3f439-4cbc-4aeb-b700-d8deb81c9c36\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-b1d3f439-4cbc-4aeb-b700-d8deb81c9c36')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-b1d3f439-4cbc-4aeb-b700-d8deb81c9c36 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_22dea0ba-1bd3-4dc9-9d26-66faeffe5338\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_22dea0ba-1bd3-4dc9-9d26-66faeffe5338 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 3,\n  \"fields\": [\n    {\n      \"column\": \"Key Items\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Key Item 1: Argument summary 1\",\n          \"Key Item 2: Argument summary 2\",\n          \"Key Item 3: Argument summary 3\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<google.colab._quickchart_helpers.SectionTitle at 0x7ab264272f50>"
            ],
            "text/html": [
              "<h4 class=\"colab-quickchart-section-title\">Categorical distributions</h4>\n",
              "<style>\n",
              "  .colab-quickchart-section-title {\n",
              "      clear: both;\n",
              "  }\n",
              "</style>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "from matplotlib import pyplot as plt\n",
              "import seaborn as sns\n",
              "df.groupby('Key Items').size().plot(kind='barh', color=sns.palettes.mpl_palette('Dark2'))\n",
              "plt.gca().spines[['top', 'right',]].set_visible(False)"
            ],
            "text/html": [
              "      <div class=\"colab-quickchart-chart-with-code\" id=\"chart-5304743e-5174-457e-8c34-aa5fab91571e\">\n",
              "        <img style=\"width: 180px;\" src=\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAtYAAAGZCAYAAACt9nbiAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90\n",
              "bGliIHZlcnNpb24zLjEwLjAsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvlHJYcgAAAAlwSFlzAAAP\n",
              "YQAAD2EBqD+naQAAMr9JREFUeJzt3XlYVeX+///XBtJOSQ7lkFNIRIkCGwQJFSIcsMKpnEqOmiWZ\n",
              "iql88lOftOyUOXQaLCvlXDQY0aQdPSexUUzUTDFBO6hpipqmeRzBcADW9w9/rp/k0N524xZ8Pq5r\n",
              "X5dr7Xut+71uqP3i5l4Lh2VZlgAAAAD8KV6eLgAAAACoDgjWAAAAgAEEawAAAMAAgjUAAABgAMEa\n",
              "AAAAMIBgDQAAABhAsAYAAAAMIFgDAAAABhCsAQAAAAMI1sBFNH36dE+XAAAAKgnBGriItm3b5ukS\n",
              "AABAJSFYAwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAA\n",
              "AAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAM\n",
              "IFgDAAAABhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBY\n",
              "AwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACHZVmWp4sALhcR4T0Vf9uDni4DAIBqZ9pLiZ4ugRlr\n",
              "AAAAwASCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAA\n",
              "AMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAMIFgDAAAABhCsAQAAAAMI1gAAAIABBGsAAADA\n",
              "AII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACC\n",
              "NQAAAGAAwRoAAAAwoFKDtZ+fn/Ly8iRJR48eVY8ePdSnTx8dP378T5+7sLBQderUsbcnTpyoo0eP\n",
              "/unzns+3334rp9Mpp9OpVq1a6aGHHtKxY8dcPj47O1sOh0PvvvtuJVZZuQ4ePKgpU6Z4ugyP6tKl\n",
              "i0JCQuR0OhUTE6M1a9Z4uiQAAHAJuCgz1kVFRbrjjjvUsGFDffjhh6pRo4bxPp5++ulKD9ahoaFa\n",
              "tWqV8vLytG7dOv366696/fXXXT4+PT1dHTt2VHp6+jnblJaWmii10lTHYO3umH/00Udau3at8vLy\n",
              "NHbsWA0ePLhyCgMAAFVKpQfrffv2KT4+XlFRUUpLS5OX18ku3333XUVFRSk8PFyxsbHKz8+XJAUH\n",
              "B2v58uX28WlpaerXr995+xg2bJgkKSYmRk6nU7/++quKioo0dOhQtW3bViEhIUpOTrZnyuPi4pSa\n",
              "mqrY2Fg1b95cEyZMUFZWljp06CA/Pz+9+OKLZ+3nqquu0hVXXCFJOn78uEpKSuRwOFwah4MHD2rB\n",
              "ggXKyMhQQUGBNm/ebL83ePBgDRkyRLGxsWrdurUk6amnnlJAQIAiIyM1fvx4+fn5STpzpr64uLhC\n",
              "DQ6HQ5MmTVJUVJT8/Pw0b948TZ48WREREbrpppu0ePFiu+3nn3+uDh06qE2bNmrbtq2ys7MlSYsX\n",
              "L1br1q01fPhwhYaGqlWrVsrNzbXHuqioSE6nUxEREWdc56ZNm9S+fXuFhoYqODhY48ePl3TyNwqj\n",
              "R4+2282YMcMOpG+//bY6deqke++9V0FBQWrXrp0KCgrUq1cvtWzZUl26dFFxcbF9nr59+6pbt24K\n",
              "DAxUYmKifvjhByUkJCgwMFD33nuvysvLJUmZmZmKiopSWFiYQkND9e9//9vuPy4uTqNGjVJ0dLS6\n",
              "dOmikSNH6rnnnrPf37hxo5o1a3bW0H36+B86dOic3wPHjh3T4cOHK7ys/682AABQ/VR6sO7Xr586\n",
              "depUYZZz2bJlev/997VkyRJ9//33mjRpku677z5J0qhRozRjxgy77WuvvaaRI0eet4+ZM2dKknJy\n",
              "cpSXl6cGDRooNTVVMTExWrlypfLz81VeXq7p06fbx2zbtk3Z2dnKz8/XK6+8oqysLOXk5GjZsmV6\n",
              "8skndfDgwbP2VVhYqNDQUF133XWqXbu2hg8fLknatWuXnE7nOWvMzMxUQkKCGjVqpKSkJL355psV\n",
              "3l+9erUWLFigDRs2aMGCBZo7d67WrFmjlStXaufOnee9/t+rVauWvvvuO6WnpyspKUnXX3+9cnNz\n",
              "9dxzz+nRRx+VJG3ZskUTJ05UVlaWVq9erczMTN1333320pYNGzZo0KBBys/PV0pKip544gl7rH19\n",
              "fZWXl2eH7dPNmDFDiYmJys/P17p16zR27FiXal61apWmTp2qgoIC3XjjjerWrZtmzpyp9evXq0aN\n",
              "GnrnnXfstrm5uZo9e7Y2btyooqIiPfjgg5ozZ44KCgq0fv16LVy4UJKUkJCgFStWaM2aNZo/f76G\n",
              "Dh1aYenOjz/+qCVLlmjRokVKSUlRWlqaysrKJEmvv/66kpOT5ePjc9Z6Bw4cqGbNmmnChAnnXNoz\n",
              "efJk1a5du8Lrlz0/ujQeAACg6qn0YH3XXXdpzpw52rFjh71v/vz5ys/PV1RUlJxOp1JSUrR//36V\n",
              "lJQoKSlJ2dnZ2rNnj5YuXSqHw6GYmBi3+503b56ef/55OZ1OhYWFKScnp8Isce/eveXt7a26devK\n",
              "399fiYmJcjgcatKkierXr6/CwsKzntfPz0/5+fnavXu3jh07pk8++USS1LhxY3s9+dmkp6dryJAh\n",
              "kqQhQ4bonXfesUOcJPXp00e+vr6SpK+//tredjgceuCBB9y69lMz/BERETpy5Ij69+8vSWrbtq02\n",
              "bdokSfrss8+0efNmxcbGyul0qnfv3vLy8tL27dslSQEBAYqKipIkRUdH66effnKp79jYWP3jH//Q\n",
              "E088oS+++KLC7O75REdHq3nz5nbdkZGRatiwoSQpMjLSrls6uca5bt26cjgcCg8PV1xcnHx9feXj\n",
              "46OwsDC77datW3XHHXeodevW6tmzp/bv36+tW7fa50lKSrJ/A3HzzTcrKChI8+fP15EjR/T+++8r\n",
              "OTn5nPXOnj1bO3bs0LPPPqv//d//PWubxx9/XIcOHarwur5hoEvjAQAAqp6zT8cZNGbMGIWGhiou\n",
              "Lk7Z2dlq3ry5LMvSoEGDKvzq/XSDBw/WrFmztH79eo0YMeKC+rUsS3PnzlVg4NmDzJVXXmn/29vb\n",
              "+4ztP1p3W6tWLfXv31/vvfeeHVzPJS8vT2vXrtXQoUPtZQP//e9/tXDhQiUmJtrnO5fTlxr4+PhU\n",
              "CORnW1d+6lq8vb3P2D51XZZlqXPnzsrMzDzj+J07d7o9Hqfcc889ateunb788kvNmDFDL7/8srKy\n",
              "sv6wbne+Hq627d+/v6ZMmaLevXtLkurVq1eh39+P+SOPPKKpU6dq79696ty5sx3sz2fQoEEaNmyY\n",
              "9u3bp2uvvbbCezVr1lTNmjUr7HN48SAeAACqq4vyKT927FilpKQoLi5O27ZtU/fu3ZWRkWHPjpaX\n",
              "l1dYVjBixAilpaVp0aJFGjBggEt9+Pr66tChQ/Z2z549NXXqVDtkHThwoMKM9YXYvHmzTpw4Ienk\n",
              "Gut//vOfCgkJ+cPj0tPTlZqaqm3btqmwsFCFhYV6+eWXz3kTY3x8vObOnavi4mJZllVh2UijRo1k\n",
              "WZYKCgoknZw5vRAJCQn66quvtHbtWnvfypUr//C4a665RiUlJed8ssumTZvUsGFDDRw4UNOmTdOK\n",
              "FSsknZwBz83NVVlZmX777TfNnTv3gup2x4EDB9SiRQtJUkZGhg4cOHDe9l26dNHu3bv17LPPnnP5\n",
              "0cGDB7Vr1y57e968ebr22mtVr149c4UDAIAqqdJnrE8ZPXq0vLy8dNtttyk7O1vTpk1Tr169VFpa\n",
              "quPHj+uuu+6yb4Zr2rSpwsLCFBgYqKuuusql86empqpz58666qqr9MUXX+ill17SY489JqfTKS8v\n",
              "L/n4+GjatGkKCAi44GtYtGiRXnnlFXtWtGPHjpowYYKkk2us77zzzjOWgxw9elTvvfeevvnmmwr7\n",
              "+/btq//5n//Rnj17zugnMTFR3333nZxOp+rUqaPbbrvNXlLh4+OjV199VYmJibr22mvt2Vh3BQQE\n",
              "KDMzUw899JB+++03HT9+XGFhYWedwT5dvXr1NHDgQIWEhKhWrVpnrLOeM2eOMjIyVKNGDZWXl9vr\n",
              "3++++259/PHHatmypf31/e233y6odldNnz5dvXv3Vp06dRQfH28vNTmXU8tuMjMzFR0dfdY2hw4d\n",
              "Up8+fVRSUiIvLy/Vr19fn376qcs3sQIAgOrLYVmW5ekifu/IkSO6+eablZOTY884Xm6Kiork6+sr\n",
              "y7KUmpqqkpISvfHGG54uq9pLTExUv3799Ne//rVSzh8R3lPxtz1YKecGAOByNu2lRE+XcOn95cWZ\n",
              "M2fqlltu0fDhwy/bUC2dfOpEWFiYgoKCtH37dj3zzDOeLqlay83NVUBAgLy8vOwn1AAAALjjkpyx\n",
              "BqorZqwBAKgczFgDAAAA1QTBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAAAAYQrAEAAAADCNYAAACA\n",
              "AQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEE\n",
              "awAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAMIFgDAAAABhCsAQAAAAMI1gAAAIABPp4u\n",
              "ALicxMb5a9qLiZ4uAwAAVAJmrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAA\n",
              "GECwBgAAAAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhA\n",
              "sAYAAAAMIFgDAAAABhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAG\n",
              "AAAADCBYAwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAA\n",
              "AAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAM\n",
              "IFgDAAAABhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBY\n",
              "AwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMA\n",
              "AAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMMBhWZbl6SKAy8X9rRx6PJKfZwEA\n",
              "MC3w7TJPl8CMNQAAAGACwRoAAAAwgGANAAAAGOBWsD5+/Lj97y1btujTTz9VWZnn17MAAAAAnuZW\n",
              "sG7fvr2Kioq0b98+xcTEaPLkyRoxYkRl1QYAAABUGW4F69LSUvn6+mrBggUaNGiQli1bpmXLllVW\n",
              "bQAAAECVcUFLQRYvXqz4+HhJkre3t/mqAAAAgCrGx53Gt99+u4KCglRWVqZZs2bpwIED8vFx6xQA\n",
              "AABAteRWKn711VeVn58vf39/XXHFFSorK9M//vGPyqoNAAAAqDLcCtYOh0P+/v4qLCxUaWlpZdUE\n",
              "AAAAVDluBeuXXnpJTz75pOrXr2+vrXY4HPrxxx8rpTgAAACgqnB7KcjGjRvVuHHjyqoHAAAAqJLc\n",
              "eipIkyZNCNUAAADAWbg1Y/1///d/GjVqlBITE3XllVfa+2NjY40XBgAAAFQlbgXrb7/9VrNnz9bS\n",
              "pUsrrLFeuXJlpRQHAAAAVBVuBevZs2ersLBQderUqaRyAAAAgKrJrTXWN9xwA6EaAAAAOAu3Zqwj\n",
              "IyPVt29f9e7du8Ia6+7duxsvDAAAAKhK3ArWq1evliS98cYb9j6Hw0GwBgAAwGXPrWCdnZ1dWXUA\n",
              "AAAAVZpba6xLS0v1wgsvaPjw4ZKkn376SYsWLaqUwgAAAICqxK0Z65EjR6qsrExLly6VJF177bXq\n",
              "16+fcnNzK6U4AAAAoKpwK1ivWLFCeXl5CgsLkyTVqVNHJ06cqJTCAAAAgKrEraUgpz8JRJLKyspU\n",
              "Xl5utCAAAACgKnIrWIeEhCgjI0Pl5eXavHmzhg0bpri4uEoqDQAAAKg63ArWL774onJycrR79261\n",
              "b99eXl5emjJlSmXVBgAAAFQZbgXro0ePatasWdqzZ4/27NmjWbNmqaSk5Kxt/fz8lJeXZx/Xo0cP\n",
              "9enTR8ePH//TRf/+z6pPnDhRR48e/dPnPZ9Fixapbdu2CgoKUqtWrTRu3Di3lsFs2bJFXl5eeuaZ\n",
              "Zyqxysp3Mcb6Unb//fcrMDBQoaGhat++vVatWuXpkgAAwCXCrWDdpUsXl/adrqioSHfccYcaNmyo\n",
              "Dz/8UDVq1HCvQhc8/fTTlR726tatqw8++EAFBQVavXq1li9frtmzZ7t8/Jtvvqn4+Hi99dZbsizr\n",
              "rG3Ky8sv+TXrF2OsL6bS0lK32vfq1UsFBQXKz8/X448/rj59+lRSZQAAoKpxKVgfP35chw8fVllZ\n",
              "mYqKinT48GEdPnxYO3bs0JEjR8553L59+xQfH6+oqCilpaXJy+tkd++++66ioqIUHh6u2NhY5efn\n",
              "S5KCg4O1fPly+/i0tDT169fvvLUNGzZMkhQTEyOn06lff/1VRUVFGjp0qNq2bauQkBAlJyfbM+Vx\n",
              "cXFKTU1VbGysmjdvrgkTJigrK0sdOnSQn5+fXnzxxbP2ExYWJn9/f0knb+J0Op0qLCx0ZfhUVlam\n",
              "t99+W6+88op8fX0rPPt74sSJuueee5SQkKDWrVvrl19+0axZsxQYGKjw8HA988wzcjgcdnuHw6GD\n",
              "Bw/a29ddd51dh5+fn8aPH6927dqpWbNmmjlzpt566y1FR0fLz89PH3zwgX3cqlWrFB8fr4iICIWF\n",
              "henjjz+W9P//NuCpp55SmzZtFBAQoKysrHOO9en27t2rLl26KDg4WCEhIbr//vslSW+//bZ69uxp\n",
              "t/v000/ttfmLFy9W69at9fDDDyskJETBwcFau3atBg8erODgYEVFRWnnzp32eTp16qR7771XQUFB\n",
              "ateunQoKCtSrVy+1bNlSXbp0UXFxsSTp66+/VnR0tMLCwtSqVSulp6fb/Q8ePFhDhgxRbGysWrdu\n",
              "rb///e9KTk623z948KCuu+467d+//4yvZffu3eXjc/JhOrfeeqt27tx5znB+7Ngx+7+VU6+yS/vn\n",
              "JgAA8Ce4FKwnT56sOnXq6IcfflDt2rVVp04d1alTR8HBwUpKSjrncf369VOnTp0qrMNetmyZ3n//\n",
              "fS1ZskTff/+9Jk2apPvuu0+SNGrUKM2YMcNu+9prr2nkyJHnrW3mzJmSpJycHOXl5alBgwZKTU1V\n",
              "TEyMVq5cqfz8fJWXl2v69On2Mdu2bVN2drby8/P1yiuvKCsrSzk5OVq2bJmefPLJCsH1bHbv3q05\n",
              "c+YoMTHR3ud0OrVr166ztv/888/VtGlTBQUF6YEHHqgQ8iTp22+/1ezZs1VQUKADBw5o4sSJ9vi4\n",
              "O6N65MgRLV++XNnZ2RozZox27typb7/9Vh9//LFSUlIknQyOycnJeu+995Sbm6svv/xSqampdoA9\n",
              "dOiQQkJCtHr1as2YMUNjxow551ifLiMjQy1atNC6deu0du1avfDCCy7VvGHDBj344INau3atevbs\n",
              "qfj4eD322GNat26dIiIi9PLLL9ttV61apalTp6qgoEA33nijunXrppkzZ2r9+vWqUaOG3nnnHUlS\n",
              "eHi4li5dqjVr1ignJ0d/+9vf9PPPP9vnWb16tRYsWGD3PW/ePPvr/tZbb6lHjx6qV6/eeeuePn26\n",
              "7rzzTjto/97kyZNVu3btCq+1/3VpSAAAQBXkUrB+6qmnVF5eruTkZHu5Qnl5uQ4ePKgJEyac87i7\n",
              "7rpLc+bM0Y4dO+x98+fPV35+vqKiouR0OpWSkqL9+/erpKRESUlJys7O1p49e7R06VI5HA7FxMS4\n",
              "fVHz5s3T888/L6fTqbCwMOXk5Gjz5s32+71795a3t7fq1q0rf39/JSYmyuFwqEmTJqpfv/55Z6IP\n",
              "Hz6sbt26ady4cYqIiLD35+XlqXHjxmc9Jj09XUOGDJEkDRgwQFlZWTpw4ID9/p133qmGDRtKOrmW\n",
              "u2vXrmrUqJEkaejQoW5d+6kZ/oCAAF155ZXq3bu3JCkiIkL79+/XwYMHtXz5cm3ZskV33HGHnE6n\n",
              "OnXqJEnauHGjpJMz8nfffbckKTo6Wj/99JNLfd96661auHChUlNTNX/+fF199dUuHRcQEKA2bdrY\n",
              "dQYEBOiWW26RJLVt21abNm2y20ZHR6t58+Z228jISHvsIiMj7bb79u1Tnz591Lp1a8XHx2vfvn36\n",
              "4Ycf7PP06dNHvr6+kk4+j71379568803ZVmW3njjjT/8gS4jI0MfffSR0tLSztnm8ccf16FDhyq8\n",
              "Qq5zaUgAAEAV5NYfiHnjjTfcOvmYMWMUGhqquLg4ZWdnq3nz5rIsS4MGDdJzzz131mMGDx6sWbNm\n",
              "af369RoxYoRb/Z1iWZbmzp2rwMDAs75/+vO4vb29z9g+1yxxUVGRunbtqh49emjs2LEu1bJ3714t\n",
              "WLBAK1eutK/5xIkTeu+99+zwVqtWrXMef/oykFP1lZWV2du/X+98rmtzOBxyOBwqLS2VZVlq1apV\n",
              "hWU3pxQWFqpmzZp2v7/v73yio6OVl5enr776Sp988okmTJigNWvWyMfH54JqPrV9+tfD1bbDhg3T\n",
              "nXfeqblz58rhcCg8PLxCv78f81GjRql79+5q2bKl6tevb/8RpLP58MMP9fTTT+vrr7+2Q/3Z1KxZ\n",
              "UzVr1qywz9utuxoAAEBV4tLHfN26dVWvXr0zXqf2n8/YsWOVkpKiuLg4bdu2Td27d1dGRoa2b98u\n",
              "6eQNe6f/SfQRI0YoLS1NixYt0oABA1y6CF9fXx06dMje7tmzp6ZOnWqHrAMHDlSYsb4QxcXF6tq1\n",
              "q7p27arx48e7fNzs2bPVs2dP7dixQ4WFhSosLNScOXPOWA5yyu23367PP//cXr/8+3YBAQH67rvv\n",
              "JEmffPLJede4n0u7du20detWffXVV/a+vLw8l57Y8vuxPt3WrVtVq1Yt9e3bV6+++qp+/PFHFRcX\n",
              "KyAgQGvXrlVJSYlKS0uVmZnpds3uOnDggG644QY5HA4tWbLEXsd/Lrfccov8/f2VnJx83tnqjz76\n",
              "SOPHj9dXX31lz5wDAABILgbrvLw8rVmz5ozXqf1/ZPTo0Ro9erRuu+02NW3aVNOmTVOvXr0UGhqq\n",
              "Vq1aVbiprmnTpgoLC1NSUpKuuuoqly4iNTVVnTt3tm+oe+mll/SXv/xFTqdTISEh6tixo8s3Gp7L\n",
              "9OnTtXLlSn3yySdyOp1yOp2aNGmS/f651linp6ef8QNC586dtWvXLn3//fdntA8ODtb48ePVvn17\n",
              "e5a1du3a9vsvvfSSHnnkEYWHh2vNmjW69tpr3b6WunXrasGCBXruuecUGhqqoKAgPfbYYy49keT3\n",
              "Y326xYsXq02bNnI6nWrXrp2ef/551a5dW7feeqvuvPNOtW7dWnFxcbrpppvcrtldU6ZM0WOPPSan\n",
              "06k333xTUVFRf3jM0KFDVVpaai+fOZsBAwbYj4889X2wb98+k6UDAIAqymGd69lvHnLkyBHdfPPN\n",
              "ysnJUYsWLTxdjkcUFRXZ63+nT5+uzz77TAsXLvRwVdXfyJEj1bBhw/PeN/Bn3d/KoccjWQ8CAIBp\n",
              "gW+7tnS1Mrm1xrqyzZw5U5MmTdLw4cMv21AtSY899piWLVumEydOqHHjxpo1a5anS6rWdu3apfj4\n",
              "eNWrV0+ff/65p8sBAABV1CU3Yw1UZ8xYAwBQOS6FGWs+4QEAAAAD3ArW995771kf0QYAAABc7twK\n",
              "1rfffruGDx+u8PBwpaenn/E8YgAAAOBy5VawTk5OVl5enl555RV9/fXXatGihcaNG6dt27ZVVn0A\n",
              "AABAlXBBa6xvvvlmtWzZUj4+PtqwYYM6dOigqVOnmq4NAAAAqDLcCtYrVqzQgAED5HQ6dfToUa1Y\n",
              "sUL/+te/tGHDBr322muVVSMAAABwyXPrOdbJyckaNWqU0tPTdeWVV9r7r776aj3xxBPGiwMAAACq\n",
              "CreC9dq1ayVJx44dO+O9hx56yExFAAAAQBXk1lKQdevWqXXr1rrxxhslSatXr9a4ceMqpTAAAACg\n",
              "KnErWKekpGjmzJmqX7++JCk8PFwLFiyolMIAAACAqsStYF1cXKwOHTrY2w6HQzVq1DBeFAAAAFDV\n",
              "uBWsfXx8dOLECTkcDknSjh075O3tXSmFAQAAAFWJW8F65MiR6tmzp/bu3avx48crJiaGNdYAAACA\n",
              "XHwqSGlpqXx8fJSUlCR/f3/Nnz9fx48fV0ZGhpo1a1bZNQIAAACXPJeC9YABA/Thhx9Kktq1a6d2\n",
              "7dpJkrZv3664uDht2bKl8ioEAAAAqgCXloIcO3ZMDz/8cIV9P//8s+Lj4zVmzJhKKQwAAACoSlwK\n",
              "1h9++KE2btxo/3XFn3/+WXFxcUpJSVFKSkqlFggAAABUBS4tBalZs6bmz5+vjh07SpLmzJmjESNG\n",
              "6JFHHqnU4gAAAICqwqVgfepPmU+ZMkX9+vVTYmKiOnbsaO8PCQmpvAoBAACAKsBhWZb1R41atGhx\n",
              "7hM4HNy8CLjo/lYOPR7p1lMuAQCACwLfLvN0Ca7NWG/durWy6wAAAACqNKbOAAAAAAMI1gAAAIAB\n",
              "Li0FAWBG3YQxCnzxRU+XAQAAKgEz1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAG\n",
              "AAAADCBYAwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAA\n",
              "AAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAM\n",
              "IFgDAAAABhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBY\n",
              "AwAAAAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMA\n",
              "AAAGEKwBAAAAAwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAMIFgDAAAA\n",
              "BhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAAAAYQ\n",
              "rAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGOCwLMvydBHA5aJWQqTq9O/o\n",
              "6TIAAKh2fr5/iqdLYMYaAAAAMIFgDQAAABhAsAYAAAAMIFgDAAAABhCsAQAAAAMI1gAAAIABBGsA\n",
              "AADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAAAAYQrAEAAAADCNYAAACAAQRrAAAA\n",
              "wACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAA\n",
              "gjUAAABgAMEaAAAAMIBgDQAAABhQqcHaz89PeXl5kqSjR4+qR48e6tOnj44fP/6nz11YWKg6derY\n",
              "2xMnTtTRo0f/9Hn/qM+4uDjVrl1bTqfT7eOzs7PlcDj07rvvmi/uIjl48KCmTJni6TI8atSoUfLz\n",
              "85PD4bC/vwEAAC7KjHVRUZHuuOMONWzYUB9++KFq1KhhvI+nn3660oP1Nddco2effVaZmZkXdHx6\n",
              "ero6duyo9PT0c7YpLS290PIuiuoYrN0d8969e2vp0qW64YYbKqkiAABQFVV6sN63b5/i4+MVFRWl\n",
              "tLQ0eXmd7PLdd99VVFSUwsPDFRsbq/z8fElScHCwli9fbh+flpamfv36nbePYcOGSZJiYmLkdDr1\n",
              "66+/qqioSEOHDlXbtm0VEhKi5ORke6Y8Li5Oqampio2NVfPmzTVhwgRlZWWpQ4cO8vPz04svvnjW\n",
              "furVq6cOHTro6quvdnscDh48qAULFigjI0MFBQXavHmz/d7gwYM1ZMgQxcbGqnXr1pKkp556SgEB\n",
              "AYqMjNT48ePl5+cn6cyZ+uLiYjkcDnvb4XBo0qRJioqKkp+fn+bNm6fJkycrIiJCN910kxYvXmy3\n",
              "/fzzz9WhQwe1adNGbdu2VXZ2tiRp8eLFat26tYYPH67Q0FC1atVKubm59lgXFRXJ6XQqIiLijOvc\n",
              "tGmT2rdvr9DQUAUHB2v8+PGSTv5GYfTo0Xa7GTNmaPDgwZKkt99+W506ddK9996roKAgtWvXTgUF\n",
              "BerVq5datmypLl26qLi42D5P37591a1bNwUGBioxMVE//PCDEhISFBgYqHvvvVfl5eWSpMzMTEVF\n",
              "RSksLEyhoaH697//bfcfFxenUaNGKTo6Wl26dNHIkSP13HPP2e9v3LhRzZo1O2vojo2NVdOmTc/+\n",
              "hQYAAJetSg/W/fr1U6dOnSrMci5btkzvv/++lixZou+//16TJk3SfffdJ+nkr9lnzJhht33ttdc0\n",
              "cuTI8/Yxc+ZMSVJOTo7y8vLUoEEDpaamKiYmRitXrlR+fr7Ky8s1ffp0+5ht27YpOztb+fn5euWV\n",
              "V5SVlaWcnBwtW7ZMTz75pA4ePOjWde7ateu8y0MyMzOVkJCgRo0aKSkpSW+++WaF91evXq0FCxZo\n",
              "w4YNWrBggebOnas1a9Zo5cqV2rlzp1u11KpVS999953S09OVlJSk66+/Xrm5uXruuef06KOPSpK2\n",
              "bNmiiRMnKisrS6tXr1ZmZqbuu+8+HTt2TJK0YcMGDRo0SPn5+UpJSdETTzwh6eRY+/r6Ki8vzw7b\n",
              "p5sxY4YSExOVn5+vdevWaezYsS7VvGrVKk2dOlUFBQW68cYb1a1bN82cOVPr169XjRo19M4779ht\n",
              "c3NzNXv2bG3cuFFFRUV68MEHNWfOHBUUFGj9+vVauHChJCkhIUErVqzQmjVrNH/+fA0dOtS+Pkn6\n",
              "8ccftWTJEi1atEgpKSlKS0tTWVmZJOn1119XcnKyfHx83Br70x07dkyHDx+u8FKZdcHnAwAAl7YL\n",
              "Tw0uuuuuuzRnzhwNHz5czZo1kyTNnz9f+fn5ioqKstvt379fJSUlSkpK0pNPPqk9e/Zo06ZNcjgc\n",
              "iomJcbvfefPm6dtvv7Vnn0tKSuTt7W2/37t3b3l7e6tu3bry9/dXYmKiHA6HmjRpovr166uwsNCt\n",
              "ddSNGzc+73rb9PR0TZ48WZI0ZMgQJSQk6JlnnrFr6tOnj3x9fSVJX3/9dYXtBx54wJ5NdsWpGf6I\n",
              "iAgdOXJE/fv3lyS1bdtWmzZtkiR99tln2rx5s2JjY+3jvLy8tH37dklSQECA/fWJjo7W3//+d5f6\n",
              "jo2N1aOPPqri4mLddttt6tSpk0vHRUdHq3nz5nbdJ06cUMOGDSVJkZGRdt2S1KVLF9WtW1eSFB4e\n",
              "rpo1a9pjFRYWZrfdunWrBgwYoJ9//lk+Pj7av3+/tm7dqltuuUWSlJSUpCuuuEKSdPPNNysoKEjz\n",
              "589XQkKC3n//fa1bt86l2s9l8uTJevrppyvsu8K/8Z86JwAAuHRVerAeM2aMQkNDFRcXp+zsbDVv\n",
              "3lyWZWnQoEEVfvV+usGDB2vWrFlav369RowYcUH9WpaluXPnKjAw8KzvX3nllfa/vb29z9g2udY5\n",
              "Ly9Pa9eu1dChQ+1lG//973+1cOFCJSYmSjo5y3wupy/18PHxsWdVJZ11XfmpazkV2k/fPnVdlmWp\n",
              "c+fOZ10vvnPnzgsej3vuuUft2rXTl19+qRkzZujll19WVlbWH9btztfD1bb9+/fXlClT1Lt3b0kn\n",
              "l/Kc3u/vx/yRRx7R1KlTtXfvXnXu3NkO9hfq8ccfP2PGvvHd8X/qnAAA4NJ1UW5eHDt2rFJSUhQX\n",
              "F6dt27ape/fuysjIsGdHy8vLKywrGDFihNLS0rRo0SINGDDApT58fX116NAhe7tnz56aOnWqHbIO\n",
              "HDhQYV3zxZSenq7U1FRt27ZNhYWFKiws1Msvv3zOmxjj4+M1d+5cFRcXy7KsCstGGjVqJMuyVFBQ\n",
              "IEmaPXv2BdWUkJCgr776SmvXrrX3rVy58g+Pu+aaa1RSUnLOJ7ts2rRJDRs21MCBAzVt2jStWLFC\n",
              "0skZ8NzcXJWVlem3337T3LlzL6hudxw4cEAtWrSQJGVkZOjAgQPnbd+lSxft3r1bzz777B8uP3JF\n",
              "zZo1dc0111R4ydvxxwcCAIAq6aI9x3r06NEaPXq0brvtNjVt2lTTpk1Tr1697JvjPvjgA7tt06ZN\n",
              "FRYWpqSkJF111VUunT81NVWdO3e2b1586aWX9Je//EVOp1MhISHq2LGjCgsL/9Q1/Pbbb2ratKn6\n",
              "9OmjgoICNW3aVI8//rikc6+xPnr0qN57770zfkDo27evvvjiC+3Zs+eMYxITE9WjRw85nU5FRkaq\n",
              "Tp069g2LPj4+evXVV5WYmKjIyEidOHHigq4lICBAmZmZeuihhxQaGqqWLVvq5Zdf/sPj6tWrp4ED\n",
              "ByokJOSsNy/OmTNHwcHBCgsLU79+/ez173fffbcaN26sli1bKjExUWFhYRdUtzumT5+u3r17Kyws\n",
              "TGvWrLGXmpyLw+HQAw88oAYNGig6Ovqc7R566CE1bdpUP//8sxISEhQQEGC6dAAAUAU5LMu65O6m\n",
              "OnLkiG6++Wbl5OTYM46Xm6KiIvn6+sqyLKWmpqqkpERvvPGGp8uq9hITE9WvXz/99a9/rZTz10qI\n",
              "VJ3+HSvl3AAAXM5+vt/zjwO+5P7y4syZM3XLLbdo+PDhl22olqSBAwcqLCxMQUFB2r59u5555hlP\n",
              "l1St5ebmKiAgQF5eXvYTagAAANxxSc5YA9UVM9YAAFQOZqwBAACAaoJgDQAAABhAsAYAAAAMIFgD\n",
              "AAAABhCsAQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAA\n",
              "AAYQrAEAAAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAG\n",
              "EKwBAAAAAwjWAAAAgAEEawAAAMAAH08XAFxOklvF6MX7p3i6DAAAUAmYsQYAAAAMIFgDAAAABhCs\n",
              "AQAAAAMI1gAAAIABBGsAAADAAII1AAAAYADBGgAAADCAYA0AAAAYQLAGAAAADCBYAwAAAAYQrAEA\n",
              "AAADCNYAAACAAQRrAAAAwACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAGEKwBAAAA\n",
              "AwjWAAAAgAEEawAAAMAAgjUAAABgAMEaAAAAMIBgDQAAABhAsAYAAAAMIFgDAAAABhCsAQAAAAMI\n",
              "1gAAAIABBGsAAADAAII1AAAAYICPpwsALhfHjh3TwoULVVZWJm9vb0+Xc1kpKyvTypUr1bZtW8b+\n",
              "ImLcPYex9wzG3XMqe+xvuOEGPfLII3/YzmFZlmW8dwBnOHz4sGrXrq1Dhw7pmmuu8XQ5lxXG3jMY\n",
              "d89h7D2DcfecS2XsWQoCAAAAGECwBgAAAAwgWAMAAAAGEKyBi6RmzZp66qmnVLNmTU+Xctlh7D2D\n",
              "cfccxt4zGHfPuVTGnpsXAQAAAAOYsQYAAAAMIFgDAAAABhCsAQAAAAMI1oBhmzZtUrt27RQYGKjI\n",
              "yEj95z//OWu79PR03XTTTbrxxhs1dOhQnThx4iJXWv24MvaLFi1S27ZtFRQUpFatWmncuHEqLy/3\n",
              "QLXVh6vf85JkWZbi4+NVp06di1dgNebq2K9bt05xcXFq2bKlWrZsqU8++eQiV1q9uDLu5eXlGjt2\n",
              "rIKCghQSEqLbb79dmzdv9kC11ceoUaPk5+cnh8OhvLy8c7bz6OerBcCo22+/3Xrrrbcsy7Ksjz/+\n",
              "2IqIiDijzZYtW6zrr7/e+uWXX6zy8nKrW7du1owZMy5ypdWPK2P//fffWz/99JNlWZZVUlJitW/f\n",
              "3j4GF8aVcT/lhRdesB588EGrdu3aF6e4as6VsT9y5IjVokULKycnx7IsyyotLbV+/fXXi1lmtePK\n",
              "uP/zn/+02rZtax0/ftyyLMt65plnrD59+lzMMqudb775xtqxY4d1ww03WGvWrDlrG09/vjJjDRj0\n",
              "66+/Kjc3V0lJSZKke+65Rzt27DhjlmLOnDnq3r27GjVqJIfDoWHDhun999/3RMnVhqtjHxYWJn9/\n",
              "f0nSlVdeKafTqcLCwotdbrXh6rhL0n/+8x/NmzdPjz322MUus1pydewzMzN16623qkOHDpIkb29v\n",
              "1a9f/6LXW124Ou4Oh0PHjh3T0aNHZVmWDh8+rKZNm3qi5GojNjb2D8fQ05+vBGvAoB07duj666+X\n",
              "j4+PpJP/Y23evLm2b99eod327dt1ww032Nt+fn5ntIF7XB370+3evVtz5sxRYmLixSqz2nF13E+c\n",
              "OKGhQ4dq1qxZ8vb29kSp1Y6rY19QUKCaNWsqMTFRTqdTAwcO1N69ez1RcrXg6rh369ZNcXFxatSo\n",
              "ka6//np9/fXX+tvf/uaJki8rnv58JVgDuCwdPnxY3bp107hx4xQREeHpcqq9p59+Wnfffbdatmzp\n",
              "6VIuO6Wlpfrqq680a9YsrVmzRk2aNNHDDz/s6bKqvdzcXP3www/auXOndu3apY4dO2rYsGGeLguV\n",
              "jGANGNSsWTP98ssvKi0tlXTyRq3t27erefPmFdo1b95c27Zts7cLCwvPaAP3uDr2klRUVKSuXbuq\n",
              "R48eGjt27MUutVpxddy/+eYbvfrqq/Lz81OHDh10+PBh+fn5MXP6J7jz/5vbb79dTZo0kcPhUFJS\n",
              "klasWOGJkqsFV8d99uzZ9o26Xl5eGjRokLKzsz1R8mXF05+vBGvAoAYNGig8PFwZGRmSpLlz56pp\n",
              "06YKCAio0O6ee+7Rv/71L+3evVuWZWnmzJnq37+/J0quNlwd++LiYnXt2lVdu3bV+PHjPVFqteLq\n",
              "uOfk5Gjbtm0qLCzU0qVLdc0116iwsJC1vn+Cq2Pft29frVq1SocPH5YkZWVlKTQ09KLXW124Ou7+\n",
              "/v5atGiRjh8/Lkn69NNP1bp164te7+XG45+vF+02SeAysWHDBuvWW2+1brrpJqtNmzbW2rVrLcuy\n",
              "rAceeMCaP3++3S4tLc3y9/e3/P39rSFDhth3juPCuTL2zz77rOXj42OFhobar2effdaTZVd5rn7P\n",
              "n7J161aeCmKIq2M/e/Zsq1WrVlZwcLDVtWtXa/v27Z4quVpwZdyPHj1qPfjgg9Ytt9xiBQcHW507\n",
              "d7afSIQLk5ycbDVp0sTy9va2GjRoYN14442WZV1an68Oy7KsixfjAQAAgOqJpSAAAACAAQRrAAAA\n",
              "wACCNQAAAGAAwRoAAAAwgGANAAAAGECwBgAAAAwgWAMAAAAGEKwBAAAAAwjWAAAAgAEEawAAAMAA\n",
              "gjUAAABgwP8DEOlQ1GRwGAYAAAAASUVORK5CYII=\n",
              "\">\n",
              "      </div>\n",
              "      <script type=\"text/javascript\">\n",
              "        (() => {\n",
              "          const chartElement = document.getElementById(\"chart-5304743e-5174-457e-8c34-aa5fab91571e\");\n",
              "          async function getCodeForChartHandler(event) {\n",
              "            const chartCodeResponse =  await google.colab.kernel.invokeFunction(\n",
              "                'getCodeForChart', [\"chart-5304743e-5174-457e-8c34-aa5fab91571e\"], {});\n",
              "            const responseJson = chartCodeResponse.data['application/json'];\n",
              "            await google.colab.notebook.addCell(responseJson.code, 'code');\n",
              "          }\n",
              "          chartElement.onclick = getCodeForChartHandler;\n",
              "        })();\n",
              "      </script>\n",
              "      <style>\n",
              "        .colab-quickchart-chart-with-code  {\n",
              "            display: block;\n",
              "            float: left;\n",
              "            border: 1px solid transparent;\n",
              "        }\n",
              "\n",
              "        .colab-quickchart-chart-with-code:hover {\n",
              "            cursor: pointer;\n",
              "            border: 1px solid #aaa;\n",
              "        }\n",
              "      </style>"
            ]
          },
          "metadata": {}
        }
      ]
    }
  ]
}